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Abstract 
 
Functions and signaling mechanisms of the membrane androgen 
receptor ZIP9 in Atlantic croaker (Micropogonias undulatus) and 
zebrafish (Danio rerio) ovaries 
 
Aubrey Koch Converse, Ph.D. 
The University of Texas at Austin, 2018 
 
Supervisor:  Peter Thomas 
 
The overall goal of this research was to further characterize and verify the role of ZIP9 in 
mediating androgen-induced apoptosis of teleost granulosa/theca (G/T) cell co-culture. In 
addition, a global ZIP9 knockout zebrafish model was used to infer other roles of the 
receptor in the ovary, in vivo. While ZIP9 was first identified and found to mediate 
apoptosis of croaker G/T cells, little was known on the signaling mechanism mediated by 
the receptor. Therefore, stimulatory G protein alpha subunit-mediated signaling, MAP 
kinase (MAPK) activity, and the role of extracellular zinc were investigated in ZIP9-
mediated apoptosis of croaker G/T cells. Additionally, the role of ZIP9 in mediation of 
testosterone-induced anti-apoptotic response observed in croaker G/T cells from fish 
outside of the reproductive peak was examined. To determine if ZIP9 mediates androgen-
induced apoptosis in G/T cells of other teleosts, a zebrafish primary G/T culture system 
was used to examine androgen-mediated events. Finally, a global ZIP9 knockout zebrafish 
 vii 
strain was developed to examine the effects of global ZIP9 knockout on female 
reproduction.  
The ZIP9-mediated apoptotic pathway in croaker G/T cells was found to require 
stimulatory G protein signaling and MAPK activity. Additionally, extracellular zinc is 
essential for the induction of ZIP9-mediated apoptosis in this model, and downstream 
responses to these signaling cascades include increased mRNA expression of pro-apoptotic 
protein members and caspase 3 activity. Pro- and anti-apoptotic effects of testosterone on 
croaker G/T cells was confirmed, and both responses were found to be mediated by ZIP9 
in an ovarian follicle stage-dependent manner. ZIP9 activation of stimulatory and 
inhibitory G proteins elicits the pro- and anti-apoptotic responses, respectively. In pooled 
zebrafish G/T cells, testosterone treatment results in an increased incidence of apoptosis, 
caspase 3 activity, upregulation of pro-apoptotic protein member mRNA, and a rapid rise 
in intracellular free zinc. This testosterone-mediated response was attributed to ZIP9 
activity, thus, ZIP9 mediates apoptosis through a similar mechanism in zebrafish G/T cells 
as observed in croaker. Finally, examination of ZIP9 global knockout zebrafish 
demonstrated that ZIP9 mutation results in reduced fecundity and abnormal egg 
phenotypes, even though no abnormalities in ovarian morphology were apparent through 
histological examination.  
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Chapter 1:  Introduction 
Cellular apoptosis 
Cell death typically occurs through two mechanisms. Apoptosis is a cell-mediated, 
energy-dependent form of cell death, while necrosis is a passive, energy-independent 
process that results in an inflammatory response (1). Apoptosis is genetically programmed 
to allow for the elimination of cells at different periods of development and is essential for 
the maintenance of homeostasis. Apoptosis can also be triggered by external and internal 
cellular stressors, which differ between cell type and stimuli. There are two primary 
mechanisms of apoptosis, the intrinsic and extrinsic pathways. The intrinsic pathway of 
apoptosis is characterized by the formation of a permeability pore in the mitochondrial 
outer membrane, which leads to the release of cytochrome C and the subsequent activation 
of caspases, or apoptotic specific proteases. The extrinsic apoptotic pathway involves 
ligand binding to a transmembrane receptor which results in the recruitment of adaptor 
proteins and procaspase-8 to form a death inducing signaling complex (DISC) that results 
in the activation of various caspases. 
The intrinsic pathway can be initiated by various stressors, such as oxidative or 
metabolic stress (2,3), DNA damage (4), heat shock (5), toxicants (6,7), and by the absence 
or presence of growth factors (8,9). Cellular stress leads to the activation of pro-apoptotic 
members of the Bcl-2 protein family (10,11). The Bcl-2 family also contains pro-survival 
proteins that act to prevent apoptosis in healthy cells. Activation of pro-apoptotic or pro-
survival members of the Bcl-2 family can shift a cell’s fate towards apoptosis or survival, 
respectively. Once activated, pro-apoptotic Bcl-2 proteins form permeability pores in the 
mitochondrial outer membrane, resulting in the release of cytochrome C to the cytoplasmic 
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compartment (11). Cytochrome C release results in the development of apoptosomes, 
which consist of cytochrome C, deoxyadenosine triphosphate (dATP), apoptotic protease 
activating factor 1 (Apaf-1), and caspase 9 (10). Once an apoptosome is assembled, caspase 
9 is activated which in turn leads to the activation of other caspases, including caspase 3 
(10). Caspase 3 is considered an execution caspase (10) that when activated directs DNA 
and protein degradation (12), resulting in cell death. While numerous factors can influence 
cell apoptosis, steroid hormones are known to play a role in the regulation of apoptosis in 
both reproductive (13–15), and non-reproductive tissues (13). 
Classical vs. nonclassical steroid action 
Steroid hormones can act through both classical and nonclassical (nongenomic) 
modes of action. Classical steroid action involves the diffusion of the steroid through the 
plasma membrane of the target cell, binding to a nuclear receptor in the cytosol, and 
subsequent dimerization of bound receptors that allows for the complex to translocate to 
the nucleus where it acts as a transcription factor to alter expression of target genes (16). 
These changes in gene expression result in the observable physiological responses that are 
associated with the steroid hormone’s action in target tissues. This classical mode of steroid 
action is relatively slow due to the time required to complete transcription and protein 
translation.  
Nonclassical steroid actions are characterized by the rapid activation of intracellular 
signal transduction pathways, which occur too rapidly to be associated with classical 
genomic mechanisms (17). Some of these rapid responses include an increase in 
intracellular calcium (18–20), adenylyl cyclase activation and inhibition (21–26), and 
activation/inhibition of the protein kinases (21,24,26–31). These responses can occur on a 
timescale of seconds to minutes and are often initiated by activation of G proteins by 
receptors on the cell surface. This results in signaling cascades similar to those mediated 
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by peptide hormone activation of members of the G protein-coupled receptor (GPCR) 
superfamily. In addition to acting directly to mediate physiological changes, rapid signaling 
members can act to mediate events that ultimately result in altered gene transcription, or in 
a pregenomic fashion. 
Nonclassical androgen actions 
Nonclassical steroid actions have been reported for all major groups of steroid 
hormones, and the field of membrane-mediated steroid action has rapidly progressed in the 
last two decades. Membrane progestin and estrogen receptors were first cloned and 
characterized in 2003 and 2005 respectively (32–34). These receptors were found to 
mediate various nonclassical actions in an array of vertebrate cells and tissues. Nonclassical 
androgen actions have also been observed in a broad number of cell and tissue types, but 
the underlying mechanism and receptor mediating many of these responses are elusive. 
Nonclassical membrane-initiated androgen actions have been reported in the brain (27,35–
37), Sertoli cells (38–40), granulosa cells (41), T cells and macrophages (42,43), oocytes 
(44–46), and a number of cancer cell lines including prostate (39,47–51), colon (52), and 
breast (53). While several of these responses were found to require expression of the 
nuclear androgen receptor (AR) (40,45), a number of these models are AR-negative (PC-3 
and DU145 prostate cancer cell lines (28,39), and IC-21 macrophages (43)). Thus, while 
some nonclassical androgen actions can be regulated by the AR acting in a nonclassical 
fashion, there must be additional ways in which androgens can mediate nonclassical 
actions.  
Interestingly, a number of responses mediated by nonclassical androgen actions are 
shared between various tissue and cell types. Androgen regulation of rapid intracellular 
calcium fluxes has been observed in pituitary cells (36), Sertoli cells (38,39), granulosa 
cells (41), T cells and macrophages (42,43), and in prostate cancer cell lines (39,48). 
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Likewise, androgen-induced apoptosis has also been observed in a number of models 
including LNCaP and DU145 prostate cancer cells (28,50), Caco2 and HCT116 colon 
cancer cell lines (29), T47D breast cancer cells (53), cortical astrocytes (37), and C6 glial 
cells (27). These analogous responses mediated through androgens acting on the cell 
surface suggest that there may be a common underlying mechanism that can mediate 
nonclassical androgen actions in vertebrates.  
Androgens action in the ovary 
Androgens have been found to be involved in various processes within the ovary 
including follicle growth (54–57), follicle cell proliferation (55,58), the transition of 
follicles to more advanced stages (56,57,59), cell survival (55), and in apoptosis and atresia 
(60–65). These differential effects of androgens between studies may be due to differences 
in experimental design, the model organism used, and the follicle stages in which the 
functions were examined. In addition, androgen effects in the ovary are typically attributed 
to AR action due to the limited evidence and understanding of actions mediated through 
membrane androgen receptors distinct from the nuclear receptor. Thus, in many studies, 
androgen effects were never directly linked to AR action through loss of function 
verification methods. The most informative studies on potential mechanisms include those 
performed in nuclear androgen receptor knockout (ARKO) models. Murine global ARKO 
models have been used to investigate the role of the AR in female reproduction in a number 
of studies (66–70). ARKO results in reproduction impairments including longer estrous 
cycles (68), increase in atretic or unhealthy follicles (68,70), reductions in follicle numbers 
(66,69), corpora lutea (68,70), and litter size (67–70), and premature ovarian failure with 
age progression (66,69). However, complete female infertility was not observed in any 
ARKO model, indicating that the AR plays a significant role in female fecundity, but is not 
essential for female reproduction. Recent studies using granulosa cell-specific ARKO 
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models have reported similar effects to global ARKO models such as increases in 
apoptosis/atresia (71–73) and decreased litter size (71,72), but again animals were only 
subfertile. These studies provide evidence for the role of the nuclear AR in normal 
folliculogenesis and suggest that androgens may be anti-apoptotic when acting through the 
AR, and thus may account for many of the actions of androgens reported in non-knockout 
models. However, AR knockout models do not account for the apoptotic actions of 
androgens in the ovary that have been reported in murine and porcine models (60–65).   
Discovery and characterization of the novel membrane androgen receptor ZIP9 
In 2004, Braun and Thomas (74) reported testosterone binding to the membrane 
fraction of Atlantic croaker ovary fragments, which was later the basis for characterization 
of a putative membrane androgen receptor in croaker ovarian tissues. The putative receptor 
was found to be homologous with the zinc transport protein ZIP9, which is the lone member 
of the SLC39A9 subfamily I (25). ZIP9 was the first, and still the only membrane androgen 
receptor identified to date that shows a high affinity, limited capacity, single binding site 
specific to androgens (25). Interestingly, ZIP9 was found to mediate androgen-induced 
apoptosis of primary croaker granulosa/theca (G/T) cell co-culture, as well as in a SKBR-
3 breast cancer cell line expressing recombinant croaker ZIP9 (ZIP9-SKBR-3) (25,75). 
Subsequently, human recombinant ZIP9 was characterized and found to mediate androgen-
induced apoptosis in ZIP9 transfected PC-3 (ZIP9-PC-3) prostate cancer cells and MDA-
MB-231 breast cancer cells. Similarly, endogenous human ZIP9 was examined in LNCaP 
prostate cancer cells and the MDA-MB-468 (468) breast cancer cells (26). With the 
exception of the LNCaP prostate cancer cell line, all of the human cell lines used for ZIP9 
characterization are AR-negative.  
ZIP9 was found to be coupled to an inhibitory G protein (Gi) in the cancer cell line 
models, but to a stimulatory G protein (Gs) in the croaker ZIP9-SKBR-3 model (25,26). It 
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is unknown whether this difference is due to the difference in species (croaker vs. human), 
or a difference in cell type (reproductive vs. malignant). In both models, ZIP9 is activated 
by testosterone and induces an apoptotic response. This response involves a rapid increase 
in free intracellular zinc (25,26), which when chelated, abrogates the apoptotic response. 
In the croaker model, ZIP9 activation of a Gs leads to increased adenylyl cyclase activity 
and increased cyclic AMP (cAMP) levels (25). In the cancer cell models, ZIP9 activation 
of a Gi inhibits adenylyl cyclase activity and results in decreased cAMP levels (26). It is 
not clear if G protein α-subunit signaling is significant in the croaker G/T cell or human 
cancer cell line models since ZIP9 activates different G proteins between these models. In 
addition, the apoptotic pathway in the human cells involves Erk activation (468 cells), the 
upregulation of pro-apoptotic members p53 and Bax, and caspase 3 activation (26). 
However, these signaling members have not been examined in the croaker ZIP9 model to 
date. 
Of interest, while ZIP9 has been found to mediate androgen-induced apoptosis in 
croaker G/T cells, preliminary research (Zhang thesis (75)) has indicated that testosterone 
mediates different survival responses of G/T cells depending on the reproductive stage of 
the fish (75). G/T cells from fish at the peak of their reproductive cycle, typically show the 
apoptotic response to testosterone, which was confirmed to be mediated by ZIP9 by Berg 
et al. 2014 (25). In contrast, in G/T cells from fish outside the peak of the reproductive 
season, testosterone is protective against cell death (75). However, the role of ZIP9 in this 
anti-apoptotic effect has not been examined.  
This dissertation seeks to further characterize the ZIP9-mediated apoptotic pathway 
in croaker G/T cells. The anti-apoptotic response exhibited by G/T cells from fish outside 
of the peak of the reproductive season will also be examined to determine if opposing 
effects of androgens can be attributed to different stages of follicle development. 
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Furthermore, the role of ZIP9 and the AR will be examined in the anti-apoptotic response. 
To date, the role of ZIP9 has only been examined in the ovary of croaker. To determine if 
ZIP9-mediates G/T cell apoptosis in the ovary of other teleosts, a G/T cell culture system 
will be utilized to examine the role of ZIP9 in zebrafish ovaries. Additionally, because 
zebrafish are a genetic model organism, a CRISPR-cas9 system will be used to establish a 
ZIP9 knockout mutant strain. ZIP9 knockout fish will be assessed for morphological and 
reproductive phenotypes that can be attributed to ZIP9 knockout.  
Overall Goals 
The overall goal of this research is to test the hypotheses that ZIP9 plays an 
important physiological role in the teleost ovary, and that the signaling mechanisms and 
functions of the receptor are conserved in teleosts. Five objectives were developed to 
examine these hypotheses.  
1. To further characterize ZIP9-mediated apoptosis and the role of pro-apoptotic proteins 
Bax, p53, and JNK. 
2. To characterize the role of MAPK (Erk) and the Gsα-subunit-mediated pathway in 
ZIP9-mediated apoptosis of croaker G/T cells.   
3. To determine the role of extracellular zinc in the induction of apoptosis by ZIP9 in 
croaker G/T cells.  
4. To determine if ZIP9 mediates the anti-apoptotic response observed in croaker G/T 
cells from fish outside the peak of the reproductive season. 
5. To investigate the role of ZIP9 in zebrafish G/T cells and overall ovarian physiology 
by comparison of ZIP9 knockout zebrafish with a wild-type model 
 
 
 
 
 
 8 
 
 
Chapter 2:  Membrane androgen receptor ZIP9 induces croaker 
ovarian cell apoptosis via stimulatory G protein alpha subunit and MAP 
kinase signaling1 
ABSTRACT 
Recent studies show that androgen-induced apoptosis in Atlantic croaker primary 
granulosa/theca (G/T) cells and in human breast and prostate cancer cell lines is mediated 
by the novel membrane androgen receptor ZIP9 which belongs to the SLC39A zinc 
transporter family. However, the apoptotic signaling pathways remain unclear because 
ZIP9 activates an inhibitory G protein in human cancer cells, whereas recombinant croaker 
ZIP9 activates a stimulatory G protein (Gs) in transfected cancer cells. Here we investigated 
androgen-dependent apoptotic pathways in order to identify the signaling pathways 
regulated through wild-type croaker ZIP9 in ovarian follicle cells. We show that the ZIP9-
mediated apoptotic signaling pathway in croaker G/T cells shares several pro-apoptotic 
members with those in human cancer cells, but is activated through a Gsα subunit-
dependent pathway. Testosterone treatment of croaker G/T cells increased intracellular 
zinc levels, Erk activity, caspase 3 activity, mRNA levels of pro-apoptotic members Bax, 
p53, and JNK, and the incidence of apoptosis, similar to findings in mammalian cancer 
cells, but also increased cAMP concentrations. Transfection with small interfering RNA 
targeting croaker ZIP9 blocked the testosterone-induced increase in bax, p53, and jnk 
expression. Testosterone-induced apoptosis and caspase 3 activation were dependent on 
the presence of extracellular zinc and were effectively blocked with co-treatment of 
                                                 
1 Chapter 2 has previously been published (with slight modification) as: Converse A, Zhang C, Thomas P. 
Membrane androgen receptor ZIP9 induces croaker ovarian cell apoptosis via stimulatory G protein alpha 
subunit and MAP kinase signaling. Endocrinology. 2017;158(9):3015–3029. The dissertator’s contributions 
included design and performing of experiments, data analysis, and writing of the manuscript. 
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inhibitors of the Gsα subunit, adenylyl cyclase, PKA, and Erk activation. These results 
indicate that ZIP9-mediated testosterone signaling in croaker G/T cells involves multiple 
pathways, some of which differ from those activated through ZIP9 in human cancer cells 
even though a similar apoptotic response is observed.  
INTRODUCTION 
Androgens regulate important ovarian processes in vertebrates including 
folliculogenesis, proliferation, and apoptosis (54,55,59,61,64,76), but the mechanisms 
controlling these functions are often unclear. Many actions of androgens are genomic and 
are regulated by the nuclear androgen receptor (AR), a ligand-activated transcription factor 
belonging to the nuclear receptor superfamily (77,78). Nuclear androgen receptor knockout 
(ARKO) models show increases in atretic and unhealthy ovarian follicles, and reductions 
in the number of corpora lutea and litter size (68,70), thus demonstrating that the AR plays 
an important role in ovarian physiology. In contrast, nongenomic androgen actions and the 
receptors that mediate them in vertebrate ovaries have received much less attention and 
remain poorly understood. Nevertheless, rapid, nongenomic androgen actions have been 
described in human and Atlantic croaker ovaries (41,79), and androgen binding moieties 
have been identified on croaker ovarian plasma membranes with binding characteristics 
different from those of ARs (74,80). More recent evidence indicated that androgens induce 
apoptosis in croaker granulosa and theca (G/T) cells by a cell surface-initiated mechanism 
that is not mimicked by the AR agonist, mibolerone, which suggests this androgen action 
is mediated by a novel membrane androgen receptor, although its identity remained 
unknown (75).  
The croaker ovarian membrane androgen receptor was subsequently cloned and 
identified as ZIP9, the sole member of the ZIP zinc transporter (SLC39A) subfamily I (25). 
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Experiments using small interfering RNA (siRNA) targeting this protein confirmed that 
ZIP9 is a membrane androgen receptor and the intermediary in testosterone-induced 
apoptosis in croaker G/T cells (25). ZIP9 is the first membrane androgen receptor to be 
identified in vertebrates and is widely expressed in croaker and human tissues (25,26). 
Human ZIP9 mediates androgen-induced apoptosis in a variety of breast and prostate 
cancer cell lines (26), which indicates that ZIP9 initiates a common response to testosterone 
in both croaker G/T primary cells and human cancer cells. Apoptosis is thought to be the 
primary mechanism regulating ovarian follicle atresia in mammals and also has been 
observed in late stage atretic follicles of teleosts (81–83). Apoptosis also plays an important 
role in the regression of the corpus luteum in mammals and post-ovulatory follicles in 
teleosts (81–85). ZIP9’s high expression in croaker ovaries and its stimulation of apoptosis 
(25) suggest that the receptor may have an important role in ovarian remodeling by 
regulating follicle cell apoptosis during the breakdown of atretic and postovulatory 
follicles. 
Although ZIP9 was first discovered in the croaker primary G/T cells, further 
characterization of the receptor was conducted with recombinant croaker ZIP9-in 
transfected SKBR3 (SKBR3-ZIP9) AR-null breast cancer cells (25), and with wild-type 
and overexpressed human ZIP9 in several AR-null breast and prostate cancer cell lines 
(26). Human ZIP9-dependent apoptosis has been well characterized in MDA-MB-468 
breast cancer cells and in PC-3 prostate cancer cells overexpressing ZIP9 (PC3-ZIP9) 
where it shows a dose-dependent, specific response to testosterone that is accompanied by 
increases in intracellular free zinc (26). The finding that testosterone treatment increases 
caspase 3 activity and mRNA levels of the pro-apoptotic regulators p53, Bax, and JNK as 
well as increased protein levels of caspase 3, Bax, and mitochondrial cytochrome C in these 
cells, indicates a plausible intrinsic apoptotic pathway through which testosterone induces 
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apoptosis and cell death in these cancer cells. Although testosterone also induces apoptosis 
and increases intracellular free zinc in croaker G/T cells, it is not known if it involves the 
same apoptotic regulators as those identified in the human cancer cell models. Information 
on testosterone regulation of pro-apoptotic regulators in croaker G/T cells would indicate 
if ZIP9 mediates apoptosis through a common mechanism in different cell types. 
The apoptosis mechanisms in croaker G/T cells and human cancer cells potentially 
could differ because recombinant croaker ZIP9 and human ZIP9 have been shown to 
activate different G proteins (25,26). In SKBR3-ZIP9 cells, croaker ZIP9 activates a 
stimulatory G protein (Gs) resulting in increased cyclic adenosine monophosphate (cAMP) 
levels (25), whereas in MDA-MB-468 and PC-3-ZIP9 cell lines human ZIP9 activates an 
inhibitory G protein (Gi) (26). The consequences of these differences in G protein 
activation in these models on their ZIP9 signaling are unknown since the pathway initiated 
by croaker ZIP9 is still obscure. In MDA-MB-468 cells, testosterone treatment increased 
Erk activation, and co-treatment with an Erk inhibitor (PD98059) effectively blocked 
testosterone-induced upregulation of pro-apoptotic genes. On the other hand, a rapid 
progestin-induced increase in Erk activity associated with a reduction in the incidence of 
apoptosis mediated by the membrane progestin receptor mPRα was observed in croaker 
primary G/T cells (24). Erk activity has not been examined in relation to ZIP9 signaling in 
G/T cells so it is not known whether Erk is primarily associated with cell survival in these 
cells, or if it may also be involved in the apoptotic response initiated by ZIP9, as observed 
with activation of mammalian ZIP9 in cancer cells. 
Interestingly, ZIP9 is the only steroid receptor identified so far that is also a zinc 
transporter. Zinc is an essential trace element that has a critical role in numerous 
physiological functions including transcriptional regulation of many genes, as a cofactor 
for hundreds of enzymes, signal transduction and rapid calcium signaling (86,87), and 
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apoptosis (88,89). Zinc homeostasis is essential for maintaining these physiological 
functions. While zinc deficiency causes cell death (90–92), a rise in intracellular free zinc 
may increase apoptosis (93,94). Intracellular free zinc levels are controlled by zinc 
transporters belonging to the ZnT and ZIP families. The ZIP zinc transporter (SLC39A) 
family transport zinc across membranes from extracellular and subcellular compartments 
into the cytosol (95). Androgen activation of ZIP9 causes a rise in intracellular free zinc in 
all the cell models in which it has been examined to date (25,26). This increase in free zinc 
levels was found to be androgen specific in the human cancer lines (26). Moreover, co-
treatment with the membrane permeable zinc-chelator N,N,N’,N’-Tetrakis(2-
pyridylmethyl)ethylenediamine (TPEN) inhibits testosterone-induced apoptosis in both 
SKBR3-ZIP9 and MDA-MB-468 cells (25,26). These results indicate that the increase in 
intracellular zinc is a critical component of the ZIP9-induced signaling pathway mediating 
apoptosis. However, the source of this increased intracellular free zinc and the role of 
extracellular zinc on ZIP9’s apoptotic functions have not been examined to date in any of 
the cell models. 
Therefore, the goal of the current study was to characterize androgen-induced 
apoptosis and its signaling pathways through wild-type croaker ZIP9 in primary G/T cells. 
The testosterone specificity of the apoptotic and zinc responses were examined and 
compared to those of the specific AR agonist mibolerone, since the AR is also expressed 
in croaker G/T cells. The testosterone regulation of pro-apoptotic members, Bax, p53, and 
JNK, through ZIP9 in croaker G/T cells was assessed for comparison with the previous 
results with human ZIP9 in cancer cells. In addition, the involvement of multiple signaling 
pathways and caspase 3 were examined in order to compare the ZIP9-mediated responses 
between the croaker G/T and human cancer cell models. A research emphasis was placed 
on the potential role of signaling induced through activation of the G protein α (Gsα) 
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subunit in ZIP9-mediated apoptosis, since this pathway is absent in the previously 
characterized human cancer cell models. Finally, the role of extracellular zinc in the 
induction of apoptosis through ZIP9 was investigated. 
MATERIALS AND METHODS 
Chemicals and materials 
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
stated. Testosterone, 17,20β,21-trihydroxy-4-pregnen-3-one (20β-S), estradiol-17β, and 
cortisol were purchased from Steraloids (Newport, RI). Mibolerone was a gift from the 
Upjohn Laboratories (Kalamazoo, MI). Bovine serum albumin-conjugated steroids were 
dialyzed to remove any free steroid by incubation with 5 mg/mL charcoal and 0.5 mg/mL 
dextran at 55°C with gentle rotation for 30 min followed by removal of charcoal by two 
centrifugation cycles at 4600 x g for 20 min each. 
Animal care and tissue collection 
Atlantic croaker were purchased from local bait shops near Port Aransas, Texas, 
and transferred to fish holding facilities at the University of Texas Marine Science Institute. 
Fish were maintained in recirculating saltwater tanks (salinity 30-32 ppt), and fed 
commercial pellets. Photoperiod was adjusted to replicate the local summer and fall 
conditions (13 hr light, 11 dark at 26°C in August; 11 hr light, 13 dark at 22-23°C in 
December) during gonadal recrudescence. Fish were acclimated to laboratory conditions 
for a minimum of 2 months before being used for G/T cell isolation. Female fish at the 
peak of the reproductive period (gonadosomatic index > 12) with oocytes averaging greater 
than 440 µm in diameter were considered reproductively mature and used for 
experimentation. Fish were deeply anesthetized by immersion in a bath containing 20 mg/L 
MS-222 and humanely euthanized by rapid decapitation in accordance with procedures 
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approved by the University of Texas Animal Care and Use Committee. Ovarian tissue was 
excised and placed in CMF buffer (138 mM NaCl, 8.6 mM KCl, 1.62 mM Na2HPO4, 5 
mM D-glucose, 15.8 mM HEPES, 1 mM EDTA, 100 mg/L streptomycin, 60 mg/L 
penicillin, pH 7.4) for G/T cell isolation. 
Primary granulosa/theca cell culture 
Unlike for mammalian ovaries, reliable methods for the separation of pure G 
(granulosa) and T (theca) cell populations from fish ovaries have not been developed; 
consequently, a co-culture system was employed. Croaker G/T cells were isolated from 
ovarian fragments by enzymatic digestion with collagenase as previously described (96). 
G/T cells were resuspended in DMEM supplemented with 3% bovine calf serum. In order 
to prevent the possible conversion of testosterone and endogenous steroid production by 
G/T cells, 100 μM of the P450 side chain cleavage and aromatase inhibitor DL-
Aminoglutethimide (Alfa Aesar, Ward Hill, MA) was added to all the culture media. In co-
culture conditions, granulosa cells predominate (approximately 60-90%) after 3 to 4 days 
of culturing when experiments are typically performed. For ZIP9 knockdown experiments, 
cells were switched to antibiotic-free media and transfected with either a mixture of ZIP9-
targeting siRNA primers or scrambled primers (Dharmacon, Lafayette, CO) twice at 0 and 
16 hr using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Treatments were administered 
24 hr after the second transfection for apoptosis and RNA expression experiments, and 3 
days after the second transfection for cAMP assay. 
Membrane protein preparation  
G/T cells were harvested by adding cold (4°C) HAED buffer (25 mM HEPES, 10 
mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.6) containing protease inhibitor (1µL/mL) to 
plates followed by scraping. All following steps were carried out at 4°C. Cells were rinsed 
2-3 times and the buffer removed by centrifugation at 1,000 x g. Cell pellets were then 
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resuspended and cells lysed by sonication for 4 s. The sample was centrifuged at 1,000 x g 
for 7 min to pellet the nuclear fractions. The supernatant containing membrane protein 
fraction was removed, placed into clean tubes, and centrifuged at 20,000 x g for 20 min to 
pellet the membrane protein fraction. The resulting pellet was resuspended in HAED buffer 
and 4X reducing sample buffer was added before boiling for 10 min, and subsequent 
storage at -80℃ until protein detection by Western blot analysis.  
Western blot analysis 
Electrophoresis was performed on membrane or whole cell lysate protein samples 
loaded on a 10% SDS-PAGE gel. Protein samples were transferred to a nitrocellulose 
membrane and blocked with 5% nonfat milk for 1 hr. After blocking, the membrane was 
incubated with the first antibody (ZIP9 1:5000 (AB_2651045); actin 1:2000 
(AB_11232819); p-Erk1/2 1:1000 (AB_331768); t-Erk1/2 1:1000 (AB_330744)) 
overnight at 4°C. The croaker ZIP9 primary polyclonal antibody was generated in mice 
against a partially-purified ovarian membrane fraction with androgen receptor activity and 
validated for measurement in this species as described previously (25). After incubation, 
the membranes were washed 3 times followed by incubation with the secondary antibody 
(HRP-linked mouse or rabbit 1:2000; LI-COR mouse 1:5000) for 1 hr. Protein bands were 
visualized using Odyssey infrared imaging system (LI-COR, Lincoln, NE) or using 
SuperSignal chemiluminescent substrate (Thermo Scientific, Grand Island, NY). 
Hoechst apoptosis analysis 
G/T cells were grown for 1-2 days on round 15 mm glass coverslips placed in 12-
well culture plates, serum-starved for 16-24 hr, and then incubated with the experimental 
treatments in serum-free DMEM (zinc: 1.5 µM) for 16 hr. At the end of the incubation, 
cells were fixed with 4% paraformaldehyde for 20 min. Cells were stained with 1µg/µL 
Hoechst 33342 for 1-5 min, rinsed with PBS (NaCl 137 mM, KCl, 2.7 mM, Na2HPO4 
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10mM, KH2PO4 1.8 mM), and mounted face down on microscope slides. Apoptotic cells 
were identified based on the morphology of chromatin under epifluorescent microscopy. 
Apoptotic nuclei in 400 cells from 2-3 replicates of each treatment were counted and 
expressed as the percent apoptotic cells. Zinc-free DMEM base (Sigma-Aldrich) media 
alone or with added zinc sulfate (1.5 µM) was used to investigate the effects of external 
zinc on the apoptosis response. Cells were washed once and incubated in the base media 
for 3 hr prior to the beginning of the experiment. Each experiment was repeated at least 
three times. 
Intracellular zinc assay  
G/T cells were grown in 96-well plates for 1-2 days until confluent. Cells were 
serum starved for 30 min followed by treatment with various steroids for 30 min. Cells 
were then fixed with 4% paraformaldehyde for 25 min at 4°C, stained with 10 µM zinquin 
ethyl esther (Enzo Life Sciences, Inc., Farmingdale, NY) for 30 min, washed, and 
immediately analyzed with fluorescence plate reader (excitation 368 nm, emission 490 
nm). Results are expressed as the relative intensity of the zinc signals compared to the 
vehicle controls. Each treatment was replicated in 8-16 wells and repeated with cells from 
at least 3 fish. 
Inhibitor treatments  
Cells were pretreated with inhibitors of caspase 3 (10 μM, Z-DEVD-FMK), caspase 
8 (10 μM, ZIETD-FMC), and Bax (50 μM, peptide V5) for 1 hr prior to co-treatment with 
testosterone. Likewise, specific inhibitors of the Gsα subunit (NF449, Cayman Chemicals, 
Ann Arbor, MI), adenylyl cyclase (2', 5'-dideoxyadenosine (dd-Ado)), Protein kinase A 
(KT5720, Biomol, Plymouth, MA), and Erk (PD98059, Biomol) were used to pretreat cells 
for 1 hr prior to co-treatment with testosterone. 
Cyclic AMP assay 
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Cyclic AMP was measured in cell lysates using a cAMP EIA kit (Cayman 
Chemicals). After isolation, G/T cells were cultured overnight, followed by serum 
starvation for 48-72 hr. Cells were treated for 10 min with vehicle or testosterone, washed 
twice with ice-cold PBS, and lysed by 20 min incubation with 100 µL 0.1 M HCl (12-well 
plate) on ice followed by scraping and repeated pipetting (20x) to homogenize the 
suspension. The suspension was centrifuged at 1,000 x g for 10 min and the supernatant 
was diluted 2-3x and either assayed immediately or stored at -80℃. Data was normalized 
and presented as relative cAMP concentration  
Caspase 3 activity 
Cells were treated as in the Hoechst apoptosis assay, harvested, and caspase 3 
activity was determined using a Caspase-Glo 3/7 Assay kit (Promega, Madison, WI) 
according to the manufacturer’s instructions. Briefly, after treatment cells were scraped, 
lysed by sonication, and the supernatant was added to a 1:1 volume of Caspase-Glo reagent. 
The luminescence of each sample was immediately analyzed by a plate reader, and 
subsequent readings were taken every 3 min. The highest luminescence value obtained for 
each sample was used and expressed relative to vehicle control values. Each experiment 
was repeated at least 3 times. 
Erk activation assay 
G/T cells grown in 12-well plates were serum starved for 48-72 hr prior to a 15-
min treatment with testosterone, EGF (100 nM) (positive control), or vehicle. Cells were 
harvested on ice using RIPA buffer (EMD Millipore, Billerica, MA) containing 
phosphatase and protease inhibitors, and the lysates were centrifuged at 15,000 x g for 5 
min to remove insoluble material. Reducing sample buffer was added, the samples were 
boiled for 10 min, and then stored at -80℃ until used for Western blot analysis. Total Erk 
and phosphorylated Erk were detected by primary antibodies directed at total p42/44 and 
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phospho-p42/44 (Cell Signaling Technology Inc.). Horseradish peroxidase-conjugated-
secondary antibodies were detected with SuperSignal chemiluminescent substrate. 
Quantitative real-time RT-PCR analysis 
G/T cells were starved for 16-24 hr prior to treatment with ethanol vehicle or 
testosterone for the indicated time (4-48 hr), followed by RNA isolation and analysis. 
Quantitative real-time PCR (qPCR) primers were designed against cloned sequences of 
bax, p53, and jnk (Table 2.1). qPCR was performed using Verso 1-step RT-qPCR SYBR 
Green Low ROX kit (Thermo Scientific), 15 µL reaction volume with 100 ng of RNA per 
reaction, following the manufacturer’s protocol. The qPCR program was set to 50°C for 
15 min, 95°C 15 min, and 40 cycles of 95°C for 15 s, 55°C for 30 s, 72°C for 30 s. 
Amplification was followed by the melting curve program, 95°C for 15 s, 60°C for 15 s 
and a gradual increase to 95°C over 20 min. Samples were run in duplicates and expression 
of target genes was normalized to the housekeeping gene 18S.  
Statistical Analysis 
All experiments were repeated at least three times with G/T cells from different 
fish. Statistical significance was determined by Student’s t-test or one- or two-way 
ANOVA with a post hoc Bonferroni multiple comparison test. The one-way ANOVA was 
used to analyze experimental results with multiple steroid treatments and concentrations. 
The two-way ANOVA was used to analyze data from the experiments in which inhibitors, 
different siRNA transfections, or multiple zinc concentrations were used. All data is 
expressed as the mean ± SEM using GraphPad Prism 5 software (GraphPad Software, San 
Diego, CA). 
RESULTS 
Characterization of the testosterone-induced apoptotic response 
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Testosterone treatment increased G/T cell apoptosis in a concentration-dependent 
manner, with concentrations of 10 nM and higher resulting in significant increases 
compared to the vehicle control (Figure 2.1A). Treatment of G/T cells with 100 nM 
estradiol (E2), cortisol, and the maturation-inducing steroid in croaker 17, 20β, 21-
trihydroxy-4-pregnen-3-one (20β-S) (97) for 16 hr had no effect on apoptosis, which 
suggests the apoptotic response is specific to androgens (Figure 2.1B). Apoptosis was not 
increased by treatment with the AR agonist, mibolerone (100 nM), which suggests the pro-
apoptotic action of testosterone is not mediated through the AR (Figure 2.1C). The male 
androgen, 11-ketotestosterone also had no effect of G/T cell apoptosis (Figure 2.1C). 
Treatment with the 5-alpha reductase inhibitor finasteride (50 µM) did not affect 
testosterone-induced apoptosis (Supplemental Figure 2.1A), which suggests that the 
apoptotic response is specific to testosterone and not a result of the conversion of 
testosterone to DHT. Treatment with 100 nM testosterone conjugated to bovine serum 
albumin (T-BSA) also resulted in a significant increase in G/T cell apoptosis compared to 
vehicle control, while treatment with E2-BSA had no effect, similar to that seen with E2 
(Supplemental Figure 2.1B/C). 
Characterization of the intracellular free zinc 
Testosterone treatment for 30 min caused a significant increase in intracellular free 
zinc over the concentration range of 10 to 50 nM, but the response was not concentration-
dependent (Figure 2.2A). Intracellular free zinc levels in G/T cells were unaltered 
compared to vehicle controls after 30 min treatment with 100 nM mibolerone and non-
androgen steroids, whereas they were significantly increased after treatment with 100 nM 
testosterone, indicating the steroid specificity of the effect (Figure 2.2B). T-BSA treatment 
also resulted in an increase in intracellular free zinc concentrations, indicating that this 
response is mediated at the cell surface (Figure 2.2C). 
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Role of caspases in testosterone-induced apoptosis 
Cells were treated with selective inhibitors of caspase 3 (10 μM, Z-DEVD-FMK) 
and caspase 8 (10 μM, ZIETD-FMC) to identify which caspases may be involved in the 
testosterone-induced apoptotic pathway in G/T cells. Co-treatment with the caspase 3 
inhibitor, but not the caspase 8 inhibitor, abolished testosterone-induced apoptosis (Figure 
2.3A,B). Furthermore, testosterone (100 nM) treatment for 16 hr caused a significant 
increase in caspase 3 activity (Figure 2.3C). 
Role of a Gsα subunit pathway in testosterone-induced apoptosis 
Treatment of G/T cells with either testosterone or T-BSA (50 nM) for 10 min 
resulted in a significant increase in intracellular cAMP levels (Figure 2.4A), indicating that 
testosterone induces a rise in cAMP levels through a cell surface-mediated mechanism. 
The role of downstream members of the Gsα subunit-mediated pathway in testosterone-
induced apoptosis and caspase 3 activity was investigated using specific inhibitors of 
activation of the Gsα subunit (10 μM, NF449), adenylyl cyclase (50 μM, dd-Ado), and 
PKA (1 μM , KT5720). Co-treatment with the inhibitors blocked the testosterone-induced 
apoptosis and increase in caspase 3 activity, whereas treatment with the inhibitors alone 
did not alter apoptosis and caspase 3 activity (Figure 2.4B,C). 
Role of Erk signaling in testosterone-induced apoptosis 
Phosphorylation of Erk was increased after incubation of G/T cells with 
testosterone (100 nM) for 15 min (Figure 2.5A). The Erk inhibitor PD98056 did not alter 
apoptosis or caspase 3 activity of G/T cells when administered alone, but co-treatment of 
the inhibitor and testosterone effectively inhibited testosterone induction of apoptosis and 
caspase 3 activity (Figure 2.5B,C).  
Role of pro-apoptotic members 
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The role of Bax in the testosterone-induction of apoptosis was investigated using a 
selective inhibitor of the protein (50 μM, peptide V5). Co-treatment with the Bax inhibitor 
abolished testosterone-induced apoptosis (Figure 2.6A). The effect of testosterone 
treatment on the regulation of pro-apoptotic members Bax, p53, and JNK was determined 
by qPCR. A 24 hr treatment with 50 nM testosterone resulted in upregulation of expression 
of bax, p53, and jnk transcripts (Figure 2.6B). A time-course experiment showed that bax 
expression is upregulated after 16 hr treatment with 100 nM testosterone (Supplemental 
Figure 2.2).  
Role of ZIP9 in testosterone-induced pro-apoptotic gene expression, apoptosis, and 
cAMP response  
siRNA was used to knockdown the expression of ZIP9 to determine whether the 
upregulation of the pro-apoptotic genes, apoptosis, and the testosterone-induced cAMP 
responses are mediated by ZIP9. ZIP9 knockdown completely abrogated the effect of 24 
hr testosterone treatment on bax, p53, and jnk mRNA expression while scrambled primers 
did not abolish the testosterone effect (Figure 2.7A-C). ZIP9 siRNA treatment also blocked 
the apoptotic response to testosterone as measured by Hoechst assay (Figure 2.7D). 
Transfection with ZIP9 siRNA also abolished the testosterone-induced increase in cAMP 
levels whereas scrambled primers were ineffective (Figure 2.7E). ZIP9 siRNA transfection 
resulted in a decrease in ZIP9 protein expression while transfection with scrambled primers 
did not affect ZIP9 levels (Figure 2.7F). 
Requirement of zinc in the culture media for testosterone-induced apoptosis 
The absence of added zinc in the zinc-free culture media resulted in an abrogation 
of the typical testosterone response, resulting in no significant difference between control 
and testosterone treatment in apoptosis as determined by the Hoechst assay (Figure 2.8A). 
The absence of supplemented extracellular zinc also resulted in the inhibition of the 
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testosterone-induced increase in bax expression (Figure 2.8B) and caspase 3 activity 
(Figure 2.8C). 
DISCUSSION  
This study provides an in-depth investigation of ZIP9’s actions in primary G/T cells 
from the croaker model in which the receptor was first cloned. Here we demonstrate that 
in Atlantic croaker G/T cells, ZIP9 elicits testosterone induction of apoptosis through a 
mechanism involving a Gsα subunit-dependent signaling pathway, Erk signaling, and the 
pro-apoptotic members caspase 3, Bax, p53, and JNK. The finding that testosterone 
treatment increases caspase 3 activity, but not caspase 8 activity, is consistent with ZIP9 
induction of apoptosis through an intrinsic pathway. Recombinant croaker ZIP9 has 
previously been shown to be coupled to a stimulatory G protein and mediate a testosterone-
induced increase in cAMP levels in transfected SKBR3 cells (25). However, the current 
data provides the first evidence for a role of a Gsα subunit-dependent pathway in ZIP9-
mediated apoptosis. Interestingly, ZIP9-induced apoptosis involves activation of an Erk 
signaling pathway, as well as upregulation of the same pro-apoptotic members in G/T cells 
as observed in human breast and prostate cancer cell lines where ZIP9 induces apoptosis 
through activation of a Gi protein (26). These findings suggest that the ZIP9-induced 
apoptosis in vertebrate cells can be regulated through different signal transduction 
pathways. Finally, the observation that the absence of supplemented zinc in the culture 
media blocked downstream testosterone-induced apoptotic events indicates that both the 
Gsα signaling and zinc transport functions of ZIP9 are required for testosterone-induced 
apoptosis in G/T cells. The discovery that the ZIP9-mediated response requires the 
presence of supplemented extracellular zinc supports the role of ZIP9 concurrently acting 
as a membrane steroid receptor and as a zinc transporter. 
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Although it is perhaps surprising that a similar downstream apoptotic mechanism 
is induced by ZIP9 in diverse cell types through activation of different G proteins, the 
ability of ZIP9 to activate multiple G proteins is not unusual and has been reported with 
other hormone receptors (17,98). For example, membrane progesterone receptor alpha 
induces the resumption of meiosis through activation of an inhibitory G protein in croaker 
oocytes whereas it causes sperm hypermotility in this species through activation of a 
stimulatory G protein (17). ZIP9 has also been shown to interact directly with the G protein 
Gnα11, which is a member of the Gqα protein family, in the murine spermatogenic GC-2 
cell line (99), which further supports the notion that ZIP9 can couple to a variety of 
different G proteins, and therefore, activate different signaling pathways to modulate cell 
functions. It remains unknown if these differences in ZIP9 activation of a particular G 
protein are a reflection of the different cell models examined, or species differences, or a 
combination of both. Further studies on G protein coupling of ZIP9 in multiple cell types 
within a species and the same cell types in different species would clarify the basis for ZIP9 
coupling to different G proteins. 
The results show that the testosterone-induced increases in caspase 3 activity and 
apoptosis in croaker G/T cells are regulated by multiple signaling pathway components, 
involving activation of the Gαs protein subunit, membrane adenylyl cyclase, protein kinase 
A, and MAP kinase (MAPK). Whereas it is well accepted that activation of the membrane 
adenylyl cyclase/cAMP/protein kinase A pathway is mediated through the Gα subunit of 
the Gs protein, the signal transduction mechanism resulting in increased MAPK/Erk 
activity remains unclear. Simultaneous activation of multiple signaling pathways through 
both the G protein α and βγ subunits is commonly observed with G protein-coupled 
receptors (100). Signaling through the βγ subunit of the G protein is a potential mechanism 
of Erk activation in G/T cells since Erk can be activated through the βγ subunits of both 
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Gi- and Gs-proteins (101). A common mechanism of Erk activation through the G protein 
βγ subunits would provide a plausible explanation of how Erk is activated through ZIP9 in 
both G/T cells and human cancer cells. Alternatively, Erk can be activated downstream of 
PKA (102), and thus the Gsα-subunit could be primarily involved in activation of both 
signaling pathways in croaker G/T cells. 
The involvement of cAMP in G/T cell apoptosis in croaker has previously been 
documented in granulosa cells isolated from rat preovulatory follicles (103,104), human 
ovum (105), and in immortalized human granulosa cells (106), which suggests that the 
induction of granulosa cell apoptosis through cAMP-dependent signaling is a common 
mechanism in vertebrate ovaries. There are no reports, to our knowledge, that testosterone 
treatment elevates cAMP concentrations in granulosa cells. However, androgens have been 
shown to increase cAMP levels in other tissues, although apoptosis was not examined in 
these studies (107,108). Many of the cAMP-related apoptotic responses in mammalian 
granulosa cells involve activation of the same pro-apoptotic members as those observed in 
the ZIP9-mediated G/T and cancer cell models, including p53 (104,106,109) and Bax 
(104). The fact that ZIP9 has been detected in human ovaries and an immortalized rat 
granulosa cell line (26), suggests it also has a physiological function in mammalian 
granulosa cells. A major question that is currently under investigation is whether the same 
pathway activated by the ZIP9-coupled Gsα subunit in androgen-induction of apoptosis of 
croaker G/T cells is activated by ZIP9 in mammalian ovarian follicle cells.  
Members of the ZIP family of zinc transporters transport zinc into the cytoplasmic 
compartment, either from the extracellular region or intracellular compartments (95,110). 
ZIP9 is no exception as demonstrated in earlier siRNA experiments in croaker G/T cells 
and MDA-MB-468 cells and in ZIP9-transfected SKBR3 and PC-3 cells, in which ZIP9 
expression was required for the increase in intracellular free zinc levels in response to 
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testosterone treatments (25,26). However, the ZIP9 zinc response differs from those 
reported to date for all the other members of the ZIP family in that is induced by a steroid 
hormone, testosterone. The present results show the highly specific zinc response to 
testosterone in G/T cells is very similar to that reported for human ZIP9 in MDA-MB-468 
cells (26). The finding that the induction of apoptosis in the G/T cells shows the same 
steroid specificity is consistent with the hypothesis that the rise in intracellular free zinc is 
required for the testosterone-mediated apoptotic response. Previous results showing that 
chelation of internal zinc with TPEN in croaker ZIP9-transfected SKBR3 cells blocked 
testosterone-induced apoptosis further support this proposed role of zinc (25). Although it 
is unclear how free intracellular zinc mediates apoptosis in this mode, zinc signaling has 
been shown to mediate cellular responses through multiple mechanisms. Zinc acts a 
cofactors to numerous enzymes and metelloproteins, but has also been shown to inhibit 
phosphotases and can stimulate calcium release (111). The present results provide the first 
evidence that extracellular zinc is required for testosterone upregulation of pro-apoptotic 
members and the completion of the apoptotic response through ZIP9. The testosterone-
induced increase in apoptosis, intracellular free zinc concentrations, and cAMP levels in 
croaker G/T cells is mimicked by T-BSA which cannot enter the cells and activate 
intracellular androgen receptors. These actions of testosterone initiated at the cell surface 
further suggest the transport of extracellular zinc across the plasma membrane into the cell 
is the primary mechanism through which testosterone causes increases in intracellular free 
zinc concentrations. ZIP9 is primarily localized on the cell membranes of croaker G/T cells 
and SKBR3-ZIP9 cells but is found in multiple cellular fractions including the 
mitochondrial, membrane, and nuclear fractions of MDA-MB-468 and ZIP9-transfected 
PC-3 cells (26), and was reported to be confined to the trans-Golgi network in the chicken 
pre-B cell line DT40 (112). Therefore, it cannot be inferred from the current experiments 
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that the testosterone-induced increase in intracellular free zinc is solely a result of ZIP9 
importing extracellular zinc into the cell. Additional research on the movement of zinc 
between cellular compartments will be required to clarify the actions of zinc in ZIP9-
mediated apoptosis.  
Mibolerone was used as a negative control in the current studies to differentiate 
androgen actions mediated through ZIP9, which does not bind mibolerone (25), from those 
regulated by the AR which is expressed in croaker ovaries and displays a high binding 
affinity for this AR agonist (80). The finding that mibolerone does not cause increases in 
intracellular free zinc and apoptosis is consistent with previous results with AR siRNA 
indicating a lack of involvement of this receptor in androgen-induced G/T cell apoptosis 
(25). Androgens have been reported to stimulate follicle growth, granulosa cell 
proliferation and inhibit apoptosis in some studies (54,55,59), while others have shown a 
pro-apoptotic effect of androgen treatment on porcine and rat granulosa cells (61,64,65). 
Murine nuclear androgen receptor knockout models exhibit decreased follicle growth and 
increases in apoptosis and atresia within the ovary (68,70,73). This suggests that the 
nuclear receptor likely plays an important role in murine folliculogenesis but not in the 
mediation of testosterone-induced apoptotic events. Differential activation of nuclear and 
membrane androgen receptors present in granulosa cells under different physiological 
conditions could partially explain the disparate effects of testosterone in the ovary, 
especially since different effects of androgens acting through intracellular and membrane 
androgen receptors have been reported in C6 glial cells (27).  
ZIP9 regulation of ovarian follicle cell apoptosis may be particularly important for 
maintenance of ovarian physiology in teleost fishes such as croaker, which release 
thousands of eggs during each spawn and require extensive gonadal reconstruction 
following oocyte release. After teleosts spawn, apoptosis is required for follicular atresia 
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and in the breakdown of the numerous post-ovulatory follicles (82–85). In contrast, 
apoptosis occurs during follicle attrition in the prenatal period and in atresia throughout 
life in mammals, but only a relatively small number of ovarian follicles undergo this 
process at any given time which may explain, at least partially, the relatively low 
expression of ZIP9 in human ovaries (26). Information on the expression of ZIP9 and its 
promotion of apoptosis in granulosa cells at different stages of follicular development in 
both teleosts and mammals will be required for a better understanding of ZIP9’s role in 
teleost and mammalian ovarian physiology. 
Based on the results presented here and prior findings (25), we propose a model for 
ZIP9 mediation of testosterone-induced apoptosis in croaker G/T cells through an intrinsic 
apoptotic pathway (Figure 2.9). In this model, testosterone binds to ZIP9 on the cell surface 
to elicit an apoptotic pathway involving increased mRNA expression of pro-apoptotic 
genes, increased caspase 3 activity, and a higher incidence of apoptosis. ZIP9 mediates 
these responses by activating a stimulatory G protein which results in increased levels of 
cAMP and MAPK activity. Both MAPK and members of the Gsα/adenylyl 
cyclase/cAMP/PKA pathway are required for testosterone-mediated caspase 3 activation 
and apoptosis. In addition, supplemented extracellular zinc is required for testosterone-
mediated increases in pro-apoptotic gene expression, caspase 3 activity, and apoptosis. 
Moreover, chelation of intracellular free zinc inhibits testosterone-induced apoptosis. This 
apoptotic response involves increased expression of JNK and P53, both of which are 
known to regulate expression of Bcl-2 family members such as Bax. Additionally, JNK 
and Bax can modulate mitochondrial membrane permeability leading to subsequent 
cytochrome c release (1,113). To date, we have shown that ZIP9 knockdown results in 
abrogation of testosterone-mediated rapid signaling events such as increases in intracellular 
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free zinc and cAMP levels, as well as downstream changes in pro-apoptotic gene 
expression, activation of caspase 3, and apoptosis.  
In summary, the present results show that testosterone activation of the novel 
membrane receptor ZIP9 results in G/T cell apoptosis through a mechanism involving Gsα 
subunit signaling and activation of the Erk signaling pathway. The activation of multiple 
pathways in the croaker G/T cell model suggests that ZIP9-mediated apoptosis is tightly 
controlled, and inhibition of any one of the numerous members of the pathway may control 
the shift between cell survival and cell death. The mechanism of action of ZIP9 through a 
Gs protein in croaker G/T cells differs from that previously examined in human cancer cell 
lines (26). The requirement of extracellular zinc for the completion of androgen-induced 
apoptotic events suggests that in addition to acting as a membrane steroid receptor, ZIP9 
also maintains zinc-transporter functions which are critical for its apoptotic functions. 
While ZIP9’s functions in ovarian physiology are not fully understood, the finding that it 
induces G/T cell apoptosis suggests it likely has a role in follicular cell apoptosis during 
atresia and postovulatory follicle breakdown. The present study further characterizes a 
recently discovered mechanism by which steroid hormones can directly influence zinc 
homeostasis through a single protein, ZIP9. This novel mechanism coordinates androgen-
induced G protein signaling pathways with zinc signaling to induce an essential cellular 
function, apoptosis, in vertebrate cells.  
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FIGURES 
Figure 2.1: Testosterone induction of 
apoptosis in croaker G/T cells. A, 
Effects of various concentrations of 
testosterone on % apoptotic nuclei. B, 
Effects of testosterone and other steroid 
treatments on % apoptotic nuclei. C, 
Effects of androgen treatments on % 
apoptotic nuclei. All data represents 
means ± SEM. Significance was 
determined by one-way ANOVA with 
Bonferroni multiple comparison post-
test. Different letters indicate 
significant differences between the 
treatment groups in the post hoc test at 
p < 0.05. Experiments were repeated 
with three fish and each treatment 
conducted in triplicate with similar 
results obtained for each. Veh, ethanol 
control; T, testosterone; E2, estradiol-
17β; Cort, cortisol; 20β-S, 17,20β,21-
trihydroxy-4-pregnen-3-one; M, 
mibolerone; 11-KT, 11-
ketotestosterone. 
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Figure 2.2: Testosterone modulation of 
intracellular free zinc levels in G/T 
cells. A, Effects of various concentrations 
of testosterone on intracellular free zinc 
levels. B, Effects of testosterone and other 
steroid treatments on intracellular free zinc 
levels. C, Effects of T-BSA on free 
intracellular zinc levels. All data represents 
means ± SEM. Significance was 
determined by one-way ANOVA with 
Bonferroni multiple comparison post-test. 
Different letters indicate significant 
differences between different treatment 
groups in the post hoc test at p < 0.05. Each 
treatment was conducted in 8-16 wells of a 
96-well plate and averaged. The 
experiments were conducted with G/T cells 
from 3-6 fish and the average values of 
each treatment were used to determine 
significance. T-BSA; testosterone 
conjugated to bovine serum albumin. 
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Figure 2.3: Role of caspases in 
testosterone-induced apoptosis. A, Effect 
of co-treatment with 10 μM caspase 3 
inhibitor (Z-DEVD-FMK) on testosterone-
induced apoptosis in G/T cells. Significant 
interactive effects of testosterone in the 
presence of the inhibitor on G/T cell apoptosis 
was detected by two-way ANOVA, which 
was predicted because the inhibitor blocked 
this androgen-induced response. B, Effect of 
co-treatment with 10 μM caspase 8 inhibitor 
(ZIETD-FMC). No significant interactive 
effects of testosterone treatment in the 
presence of the inhibitor on G/T cell apoptosis 
was detected by two-way ANOVA, which 
was predicted because the inhibitor had no 
effect on the androgen-induced response. 
ANOVAs for (A) and (B) were followed by 
Bonferroni multiple comparison test. 
Different letters indicate significant 
differences between different treatment 
groups in the post hoc test at p < 0.05. C, 
Relative caspase 3 activity after 16-hr 
testosterone treatment. Results for (C) were 
analyzed with Student’s t-test. **, p<0.01. All 
data represent means ± SEM. Apoptosis 
experiments were repeated with 3 fish and 
each treatment conducted in duplicate with 
similar results obtained for each. Caspase 3 
activity was assessed for 5 fish. NT, no 
inhibitor treatment; C3 Inhib, Z-DEVD-
FMK; C8 Inhib, ZIETD-FMC. 
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Figure 2.4: Involvement of members of 
a Gsα subunit signaling pathway in 
testosterone-mediated apoptosis and 
caspase 3 activity. A, Relative cAMP 
concentrations in G/T cells treated for 10 
min with vehicle, testosterone, or T-BSA. 
Significance was determined by one-way 
ANOVA with Bonferroni multiple 
comparison post-test. Different letters 
indicate significant differences between 
different treatment groups in the post hoc test 
at p < 0.05. B, Effects of co-treatment with 
inhibitors of the Gsα subunit, adenylyl 
cyclase, and PKA on testosterone-mediated 
apoptosis. C, Effects of co-treatment with 
inhibitors on testosterone-mediated 
activation of caspase 3. In experiments (B) 
and (C) significant interactive effects of 
testosterone treatment in the presence of 
each inhibitor on G/T cell apoptosis and 
caspase 3 activity was detected by two-way 
ANOVA, which was predicted because the 
inhibitors blocked these androgen-induced 
responses. Different letters indicate 
significant differences between different 
treatment groups in the Bonferroni multiple 
comparison post-test test at p < 0.05. All data 
represent means ± SEM. All experiments 
were repeated with 3-6 fish and each 
treatment was conducted in duplicate or 
triplicate with similar results obtained for 
each. NT, no inhibitor treatment; NF, NF449 
(10 μM); dd, dd-Ado (50 μM); PKAI, 
KT5720 (1 μM). 
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Figure 2.5: Involvement of MAPK 
signaling in the testosterone-mediated 
apoptotic pathway. A, Relative phospho-
Erk normalized to total-Erk in G/T cells 
treated with vehicle, 100 nM testosterone, or 
100 nM EGF. B, Effects of co-treatment 
with an Erk inhibitor (PD98059) on 
testosterone-mediated apoptosis. C, Effects 
of co-treatment with the Erk inhibitor on 
testosterone-mediated caspase 3 activation. 
Significance was determined by one- or two-
way ANOVA with Bonferroni multiple 
comparison post-test. Different letters 
indicate significant differences between 
different treatment groups in the post hoc 
test at p < 0.05. In experiments (B) and (C) 
significant interactive effects of testosterone 
treatment in the presence of the inhibitor on 
G/T cell apoptosis and caspase 3 activity 
was detected by the two-way ANOVA, 
which was predicted because the inhibitor 
blocked these androgen-induced responses. 
All data represent means ± SEM. All 
experiments were repeated with 3-5 fish and 
each treatment conducted in duplicate or 
triplicate with similar results obtained for 
each. NT, no inhibitor treatment; PD, 
PD98059 (10 μM).  
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Figure 2.6: Role of pro-apoptotic 
members in testosterone-mediated 
apoptosis. A, Effect of co-treatment 
with 50 μM Bax inhibitor (peptide V5) 
on testosterone-induced apoptosis in G/T 
cells. Significant interactive effects of 
testosterone treatment in the presence of 
the inhibitor on G/T cell apoptosis was 
detected by two-way ANOVA, which 
was predicted because the inhibitor 
blocked the androgen-induced response. 
In experiment (A), each treatment was 
conducted in duplicate or triplicate and 
repeated with 3 fish with similar results 
obtained for each. C, Expression of bax, 
p53, and jnk mRNA after 24 hrs of 50 nM 
testosterone treatment. In experiment (C) 
treatments were conducted in duplicate 
and repeated with 8 fish with similar 
results obtained for each. All qPCR data 
was normalized to the housekeeping 
gene 18S. All data represent means ± 
SEM. Significance was determined by 
one- or two-way ANOVA with 
Bonferroni multiple comparison post-test 
or Student’s t-test. Different letters 
indicate significant differences between 
different treatment groups in the post hoc 
test at p < 0.05. *, p < 0.05; ***, p < 0.001 
compared to control in Student’s t-test. 
NT, no inhibitor treatment; Bax Inhib, 
peptide V5. 
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Figure 2.7: Effect of ZIP9-targeting siRNA on mRNA expression of pro-apoptotic 
members, apoptosis, and cAMP levels.  
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Figure 2.7 (continued): Effect of ZIP9-targeting siRNA on mRNA expression of pro-
apoptotic members, apoptosis, and cAMP levels. A-F, Effects of ZIP9-targeting siRNA on 
the testosterone-induced increase in bax (A), p53 (B), and jnk (C) expression, apoptosis 
(D), cAMP levels (E), and on relative ZIP9 protein expression (F). All qPCR data was 
normalized to housekeeping gene 18S. In experiments (A-E) significant interactive effects 
of each steroid treatment (Veh & T) and the transfection treatments on pro-apoptotic 
member mRNA expression, G/T cell apoptosis, and cAMP was detected by the two-way 
ANOVA, which was predicted because ZIP9-targeting siRNA blocked the androgen-
induced responses. *, p < 0.05; **, p < 0.01; ***, p < 0.001 compared to control in 
Student’s t-test. In experiment (F) significance was determined by one-way ANOVA 
followed by with Bonferroni multiple comparison post-test. Different letters indicate 
significant differences between different treatment groups in post hoc test at p < 0.05. All 
data represent means ± SEM. For gene expression and apoptosis experiments, steroid 
treatments were conducted in duplicate and repeated with 5 fish with similar results 
obtained for each. For cAMP experiment steroid treatments were conducted in triplicate 
with 3 fish with similar results obtained for each. NT, no transfection; SC, scramble siRNA 
control; siRNA, small interfering RNA targeted at croaker ZIP9; actin, actin loading 
control. 
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Figure 2.8: Effect of extracellular zinc 
in testosterone-mediated apoptotic 
events. Testosterone-induction of 
apoptosis (A), bax expression 
upregulation (B), and caspase 3 activity 
(C) when the testosterone treatment 
was administered in media 
supplemented with 1.5 µM or 0 µM 
zinc. Significant interactive effects of 
testosterone at different zinc 
concentrations on G/T cell apoptosis, 
bax expression, and caspase 3 activity 
was detected by two-way ANOVA, 
which was predicted because the low 
zinc concentrations blocked these 
androgen-induced responses. All data 
represents means ± SEM. Different 
letters indicate significant differences 
between different treatment groups in 
the Bonferroni multiple comparison 
post-test at p < 0.05. All Experiments 
were repeated with 3 fish and each 
treatment was conducted in duplicate or 
triplicate with similar results obtained 
for each. 
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Figure 2.9: Proposed model of testosterone acting through ZIP9 to mediated croaker G/T 
cell apoptosis. ZIP9 is coupled to a stimulatory G protein which leads to increased cAMP 
levels and MAPK activity, which along with intracellular free zinc, are required for the 
induction of apoptosis. Further details of the model are described in the discussion. T, 
testosterone; PM, plasma membrane; αs, stimulatory G protein α-subunit; βγ, G protein βγ-
subunit; PKA, protein kinase A; Cyto C, cytochrome c; C3, caspase 3. 
 
 
 39 
SUPPLEMENTAL DATA 
Table 2.1: List of antibodies used in Chapter 2. 
 
 
Table 2.2: Sequence of primers (5’-3’) used for qPCR experiments (Chapter 2). 
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Figure 2.10: Further characterization 
of androgen-induced G/T cell 
apoptosis. A, effect of 5-alpha 
reductase inhibitor (finasteride 50 µM) 
on testosterone-mediated apoptosis. No 
significant interactive effects of 
testosterone treatment in the presence 
of the inhibitor on G/T cell apoptosis 
was detected by two-way ANOVA, 
which was predicted because the 
inhibitor had no effect on the androgen-
induced response. B/C, effects of BSA 
conjugated testosterone and estradiol 
on G/T cell apoptosis. Significance was 
determined by one-way ANOVA with 
Bonferroni multiple comparison post-
test. Different letters indicate 
significant differences between 
different treatment groups in the post 
hoc test at p < 0.05. All data represents 
means ± SEM. Experiments were 
repeated with 3 fish and each treatment 
conducted in triplicate with similar 
results obtained for each. Fin, 
finasteride (50 µM); T-BSA, 
testosterone conjugated to bovine 
serum albumin; E2-BSA, estradiol 
conjugated to bovine serum albumin.  
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Figure 2.11: Time course of testosterone’s effect on relative Bax mRNA levels. All data 
represents means ± SEM. Significance was determined by Student’s t-test. *, p < 0.05. 
Experiments were repeated with six fish and each treatment conducted in duplicate with 
similar results obtained for each. 
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Chapter 3:  The membrane androgen receptor ZIP9-mediates pro- and 
anti-apoptotic responses in Atlantic croaker ovarian follicle cells by 
activating Gi and Gs in a follicle stage-dependent manner 
ABSTRACT 
ZIP9 was previously found to mediate androgen-induced apoptosis of Atlantic 
croaker granulosa/theca (G/T) cells isolated from reproductively mature ovaries. This 
apoptotic response involves stimulatory G protein activation, increased cAMP and free 
intracellular zinc levels, and upregulation of pro-apoptotic member mRNA. Interestingly, 
preliminary evidence was obtained indicating that testosterone acts in an anti-apoptotic 
fashion in G/T cells from ovaries not at the reproductive peak. Here we show that 
testosterone-mediates both pro- and anti-apoptotic responses in a follicle stage-dependent 
manner. G/T cells from early stage follicles (diameter <300μm) exhibited the anti-
apoptotic response while G/T cells from late stage follicles (diameter >400μm) showed the 
apoptotic response. siRNA targeting ZIP9, but not the nuclear androgen receptor, blocked 
the anti-apoptotic response, indicating ZIP9 mediates both pro- and anti-apoptotic 
responses. Testosterone treatment of early stage G/T cells resulted in opposite trends in 
signaling from the ZIP9-mediated apoptotic response, with decreased cAMP and 
intracellular free zinc levels, and downregulation of pro-apoptotic member mRNA 
expression. Furthermore, activators of stimulatory G protein signaling antagonized the 
anti-apoptotic response. Proximity ligation and G protein activation assays were employed 
to determine if ZIP9 mediates these differential responses by activating different G 
proteins. In G/T cells from early stage follicles ZIP9 was in close proximity and activated 
an inhibitory G protein, while in G/T cells from late stage follicles ZIP9 was in close 
proximity and activated a stimulatory G protein. This indicates that ZIP9 mediates opposite 
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survival responses of croaker G/T cells by activating different G proteins in a follicle stage-
dependent manner. 
INTRODUCTION 
In the mammalian ovary, androgens are involved in a number of physiological 
processes such as follicle growth, proliferation, apoptosis, and atresia. These processes are 
typically exhibited at specific stages of folliculogenesis with androgens promoting growth, 
proliferation, and survival in early stage follicles, and apoptosis and atresia at later stages 
of development (54,55,58–64,114). While these processes have been better characterized 
in mammalian models, a limited number of studies have shown that androgens promote 
follicle growth of previtellogenic follicles in a number of teleosts including short-finned 
eel, Atlantic cod, and coho salmon (57,115,116). Together these studies suggest that 
androgen promotion of early follicle growth may be a shared response in mammals and 
teleosts (116). Androgens have also been reported to promote apoptosis and atresia in a 
number of mammalian models, although there are discrepancies in the follicle stages that 
exhibit these responses (60–64,114). Early in vivo studies demonstrated androgens promote 
apoptosis and follicle atresia in both preantral (60–62) and antral (61–63) murine follicles. 
However, more recent in vitro studies have indicated that the androgen-induced apoptotic 
response is primarily exhibited by antral follicle cells in porcine and murine models 
(64,114). Recently, testosterone was found to induce apoptosis of co-cultured 
granulosa/theca (G/T) cells from reproductively mature Atlantic croaker ovaries with a 
high proportion of late stage vitellogenic follicles (25,117). This suggests that androgen-
induced apoptosis in late stage follicles may also be a shared response between teleosts and 
mammals.  
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While androgens have been observed to promote a number of physiological 
responses in mammalian and teleost ovaries, a direct role of the nuclear androgen receptor 
(AR) in many of these responses remains unclear. The physiological relevance of androgen 
actions in the ovary that are mediated by the AR has been demonstrated in a number of 
murine AR knockout (ARKO) models. ARKOs are subfertile, showing reduced litter sizes, 
defective cumulus-oocyte complex formation, decreased oocyte viability, and increased 
numbers of atretic and apoptotic follicles (68,70–72). However, ARKO models have not 
been used to verify the loss of function of many androgen responses previously reported in 
in vitro and in vivo study systems. The ARKO models support a role of the AR in mediating 
growth and proliferative effects of androgens previously observed in wild-type models, but 
further work is required to confirm the role of the receptor in specific responses. An 
additional confounding factor in determining androgen mechanisms of action in the ovary 
lies in the recent discovery of the novel membrane androgen receptor ZIP9, and the finding 
that it mediates the androgen-induced apoptotic response observed in Atlantic croaker G/T 
cells (25). The zinc transport protein ZIP9 (SLC39A9) was recently cloned and 
characterized in Atlantic croaker ovaries and found to mediate apoptosis of croaker G/T 
cells independently of the AR (25). ZIP9 possesses characteristics of a membrane androgen 
receptor distinct from the nuclear receptor including the presence of a high-affinity and 
limited capacity binding site specific for androgen hormones but not for synthetic AR 
agonist and antagonists. ZIP9 expression is regulated by steroid hormones, and the receptor 
activates rapid secondary messenger cascades to induce physiological responses (25). ZIP9 
is expressed in both reproductive and non-reproductive tissues in mammals and fish, but 
information is currently lacking on the receptor’s role in mediating androgen actions in the 
majority of these tissues. To date, ZIP9 has been found to be involved in androgen-induced 
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apoptosis in a number of human cancer cell lines and croaker G/T cells, tight junction 
formation in murine Sertoli cells, and migration in glioblastoma cell lines (26,118,119). 
ZIP9 is the only known zinc transporter belonging to the ZIP (SLC39A) family that 
also functions as a steroid receptor. Interestingly, the zinc transport and androgen receptor 
characteristics of ZIP9 appear to be tightly associated in that androgens mediate 
intracellular free zinc concentrations though ZIP9 activation (25,26). In addition, the ZIP9-
mediated increase in intracellular free zinc is essential for the apoptotic response in both 
croaker G/T cells and human cancer cell lines, the regulation of which is known to involve 
G protein activation in PC-3 prostate cancer cells overexpressing ZIP9 (25,120). While 
ZIP9-mediated apoptosis involves intracellular zinc regulation, the role of ZIP9’s zinc 
transporter activity in other physiological responses the receptor mediates remains unclear.  
Membrane receptors specific for progestins and estrogens have been extensively 
studied over the last 15 years since the discovery of the membrane progestin receptor α 
(mPRα) and G protein-coupled estrogen receptor 1 (GPER), formerly known as GPR30, in 
2003 and 2005, respectively (32,34,121). It has been well established that these receptors 
mediate physiological responses by coupling to and activating G proteins, similar to that 
observed with receptors for peptide hormones in the G protein-coupled receptor (GPCR) 
superfamily. The membrane estrogen receptor GPER couples to stimulatory G proteins 
(Gs) in most models (21,121,122), although a number of studies have demonstrated that 
GPER can mediate pertussis toxin-sensitive events (123,124), suggesting that the receptor 
may also activate inhibitory G proteins (Gi). mPR’s are primarily known to couple to 
inhibitory G proteins (24,32,125,126), although coupling of mPRα to an olfactory G (Golf) 
protein has been reported in teleost sperm (127). ZIP9 has been found to activate different 
G proteins in diverse cell models, including a Gs in croaker G/T cells, a Gi in human breast 
and prostate cancer cell lines, and a Gq in the spermatogenic cell line GC-2 (25,26,99). To 
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date, ZIP9 has been found to couple to different G proteins in every cell model that ZIP9-
G protein interactions have been examined. It remains unclear if the differential coupling 
of ZIP9 to G proteins is determined by species or cell type differences, or by another 
mechanism. 
We previously reported that ZIP9 mediates androgen-induced apoptosis in G/T 
cells from reproductively mature Atlantic croaker through a nonclassical signaling pathway 
(25,117). This apoptotic response is independent of the AR and specific to testosterone. Of 
interest, preliminary data has indicated that testosterone inhibits apoptosis in G/T cells from 
fish collected outside the peak of the reproductive season whose ovaries are not fully grown 
as shown by a moderate gonado-somatic index (GSI) (75). This anti-apoptotic effect was 
not mimicked by the AR agonist mibolerone, suggesting that this response may be 
mediated by an alternative androgen receptor such as ZIP9. We hypothesize that the pro- 
and anti-apoptotic androgen-induced responses in croaker G/T cells can be attributed to 
differential effects of androgens in early and late stage follicles. This may be why G/T cells 
from fish with lower GSI’s respond differently to testosterone than G/T cells from fish with 
high GSI’s and a corresponding higher proportion of late stage vitellogenic follicles. 
Therefore, the goal of the current study was to characterize androgen actions in croaker 
G/T cells from early and late stage ovarian follicles, <300 µm and >400 µm in diameter, 
respectively. These two size classes are typical of early stage follicles that are pre- or early 
vitellogenic, and late stage follicles that have completed vitellogenesis and are competent 
to undergo final oocyte maturation. We confirmed that testosterone induces and inhibits 
apoptosis in a follicle-stage dependent manner, and further investigated the role of ZIP9 in 
both responses. Relative expression of ZIP9, as well as membrane androgen binding, was 
examined in G/T cells from early and late follicle stages. Next, we investigated the role of 
members of the known ZIP9-mediated apoptotic pathway (117) in the anti-apoptotic 
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response. Finally, we examined potential mechanisms of ZIP9 action between the apoptotic 
and anti-apoptotic models by exploring the interactions of ZIP9 with inhibitory and 
stimulatory G proteins as well as testosterone activation of these G proteins.  
MATERIALS AND METHODS 
Chemicals and materials 
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
stated. Testosterone and 4-estren-7α, 17α-dimethyl-17β-ol-3-one (Mibolerone) were 
purchased from Steraloids (Newport, RI). [1,2,6,7-3H]Testosterone ([3H]T) (100 Ci/mmol) 
was purchased from American Radiolabeled Chemicals (St. Louise, MO), and guanosine 
5’-(γ-thio)triphosphate-[35S] ([35S]GTPγS) (1250 Ci/mmol) was purchased from 
PerkinElmer (Waltham, MA). 8-bromoadenosine 3′,5′-cyclic monophosphate (8-Br-
cAMP) was purchased from Selleck Chemicals (Houston, TX). Forskolin was purchased 
from MP Biomedicals (Santa Ana, CA). N,N,N’,N’-tetrakis(2-pyridylmethyl)-1 ,2-
ethylenediamine (TPEN) was purchased from Cayman Chemicals (Ann Arbor, MI). 
GTPyS was purchased from Calbiochem (Burlington, MA). Bovine serum albumin-
conjugated testosterone (TBSA) was dialyzed to remove free testosterone by incubation 
with 5 mg/mL charcoal and 0.5 mg/mL dextran at 55°C under gentle rotation for 30 min 
followed by removal of charcoal by two centrifugation cycles at 4600 x g for 20 min each.  
Animal care and tissue collection 
Atlantic croaker were purchased from bait shops near Port Aransas, Texas, and 
transferred to holding facilities at the University of Texas Marine Science Institute. Fish 
were maintained in recirculating water tanks (salinity 30-32 ppt) and fed a diet composed 
of commercial pellets and shrimp. Photoperiod was adjusted to replicate local summer and 
fall conditions (13 hr light, 11 dark at 26°C in August; 11 hr light, 13 dark at 22-23°C in 
 48 
December) to induce gonadal recrudescence. Fish were acclimated to laboratory conditions 
for a minimum of 2 months before being used for experimentation. All experiments were 
conducted with ovaries from reproductively mature females (GSI >12). Fish were deeply 
anesthetized by immersion in a bath containing 20 mg/L MS-222 and humanely euthanized 
by rapid decapitation in accordance with procedures approved by the University of Texas 
Animal Care and Use Committee. Excised ovarian tissue was placed in Ca/Mg-free buffer 
(138 mM NaCl, 8.6 mM KCl, 1.62 mM Na2HPO4, 5 mM D-glucose, 15.8 mM HEPES, 1 
mM EDTA, 100 mg/L streptomycin, 60 mg/L penicillin, pH 7.4) for follicle separation and 
G/T cell isolation. 
Primary granulosa/theca cell culture 
Croaker ovarian follicles were separated by repeated pipetting and divided into two 
size classes, <300 µm and >400 µm, using sieves. After the follicles had been separated by 
size class, G/T cells were isolated by enzymatic digestion with collagenase as previously 
described (96). G/T cells were resuspended in Dulbecco's Modified Eagle's medium 
supplemented with 3% charcoal-stripped bovine calf serum. In order to prevent G/T cells 
from producing endogenous steroids and converting testosterone, 100 μM of the P450 side 
chain cleavage and aromatase inhibitor DL-Aminoglutethimide (Alfa Aesar, Ward Hill, 
MA) was added to all culture media. For gene silence experiments, G/T cells were 
transfected with either a mixture of ZIP9 or AR targeting siRNA primers or non-targeting 
control primers (Dharmacon, Lafayette, CO) twice, first during plating and again after 16 
hours, using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Treatments were 
administered 72 hr after the initial transfection. 
Follicle size and stage determination 
A small subset of follicles from the early and late stage pools were examined and 
imaged under bright field microscopy (4X). Images were used to characterize 120-200 
 49 
follicles from each size subset as perinuclear stage (PNS, <100 µm), early vitellogenic (EV, 
100-300 µm), or late vitellogenic (LV, >300 µm). Characterization was performed on 
follicles from 3 individual separations. 
Membrane protein preparation  
All steps were carried out at 4°C. Ovarian tissue or G/T cells were homogenized in 
ice-cold HAED buffer (25 mM HEPES, 10 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.6) 
containing protease inhibitor (1µL/mL), followed by centrifugation at 1000 x g for 7 min 
to pellet the nuclear fraction. The supernatant containing the membrane protein fraction 
was removed and centrifuged at 20000 x g for 20 min to pellet membrane proteins. For 
Western blot analyses the resulting pellet was resuspended in HAED, followed by the 
addition of 5X reducing sample buffer (Thermo Fisher Scientific, Waltham, MA), boiling 
for 10 min, and subsequent storage at -80℃. For the androgen receptor binding assay, the 
pellet was resuspended in HAED buffer with protease inhibitor. For GTPγS binding and 
precipitation assays the membrane protein pellet was resuspended in GTPγS binding buffer 
(100mM NaCl, 5 mM MgCl2, 1 mM CaCl2, 0.6 mM EDTA, 0.1% BSA, 50 mM Tris-HCl, 
pH 7.6) with protease inhibitor. 
Quantitative real-time PCR analysis 
Total mRNA was isolated using Tri-reagent (Sigma-Aldrich) following the 
manufacturer’s protocol. For expression of ZIP9 in G/T cells from different stage follicles, 
G/T cells were lysed in Tri-reagent immediately after isolation. For examining the effects 
of testosterone on the expression of the pro-apoptotic genes, G/T cells were starved for 16-
24 hr prior to a 24 hr testosterone treatment, after which mRNA isolation and analysis were 
performed. Quantitative real-time PCR (qPCR) primers were designed against the mRNA 
sequences of zip9, bax, and p53 (Table 3.1). qPCR was performed using Verso 1-step RT-
qPCR SYBR Green Low ROX kit (Thermo Scientific), with 100 ng of mRNA per 15 µL 
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reaction, following the manufacturer’s protocol. The qPCR program was set to 50°C for 
15 min, 95°C for 15 min, and 40 cycles of 95°C for 15 s, 55°C for 30 s, 72°C for 30 s. 
Amplification was followed by the melting curve program, 95°C for 15 s, 60°C for 15 s 
and a gradual increase to 95°C over 20 min. Samples were run in duplicate and expression 
of target genes was normalized to the housekeeping gene 18S.  
Western blot analysis 
Electrophoresis was performed on membrane protein samples loaded on a 10% 
SDS-PAGE gel. Protein samples were transferred to a nitrocellulose membrane and 
blocked with 5% nonfat milk for 1 hr. After blocking, the membrane was incubated with 
primary antibodies for ZIP9 1:5000, actin 1:2000 (AnaSpec, Fremont CA), Gs (Proteintech, 
Rosemont, IL), or Gi(1/2) (Abcam, Cambridge, MA)) overnight at 4°C. The croaker ZIP9 
primary antibody was generated in mice against a partially-purified ovarian membrane 
fraction with androgen receptor activity and validated for measurement in this species as 
previously described (25). After incubation, the membranes were washed 3 times with PBS 
(NaCl 137 mM, KCl, 2.7 mM, Na2HPO4 10mM, KH2PO4 1.8 mM) followed by incubation 
with secondary antibodies (1:15000) for 1 hr at room temperature. Protein bands were 
visualized using Odyssey infrared imaging system (LI-COR, Lincoln, NE). 
Androgen receptor binding competition assay 
The ability of steroid competitors to displace [3H]T binding to the membrane 
fractions of ovarian follicles in single-point competitive binding assays was assessed using 
methods described previously (74). Membrane protein (0.5-1.25 mg/ml final) was added 
to 3 nM (final) [3H]T in the presence of vehicle, or 100 nM unlabeled testosterone or 
mibolerone. Nonspecific binding was determined in the presence of 1000x unlabeled 
testosterone (3 µM) and subtracted from total binding to determine specific [3H]T binding. 
Reactions were conducted in triplicate, and the results expressed as % of specific binding.  
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Apoptosis analyses 
Croaker G/T cells grown on round glass coverslips were serum-starved for 16-24 
hr prior to the addition of steroid and/or drug treatment for 24 hours. All treatments were 
performed in duplicate or triplicate. For Hoechst staining, once treatment was complete the 
cells were fixed in 4% paraformaldehyde for 20 min at room temperature, stained with 
1µg/ml Hoechst 33342 for 2-3 min, rinsed with PBS, and mounted face down on 
microscope slides. Apoptotic nuclei were identified based on the morphology of chromatin 
under epifluorescent microscopy, and % apoptotic cells was determined by examination of 
400 cells from each slide. For TUNEL staining, cells were fixed and stained following the 
manufacturer’s protocol (In Situ Cell Death Detection Kit; Roche, Indianapolis, IN). 
Apoptosis was assessed as fluorescent staining of the nuclei, and % apoptotic cells was 
determined by examination of 800-1200 cells total from a minimum of 4 frames of view 
(10x) for each slide.  
Intracellular zinc assay  
G/T cells were grown in 96-well plates for 1-2 days until confluent. Cells were 
serum starved for 30 min followed by steroid treatment (20 nM) for 30 min. Cells were 
fixed with 4% paraformaldehyde for 25 min at 4°C, stained with 10 µM zinquin ethyl esther 
(Enzo Life Sciences, Inc., Farmingdale, NY) for 30 min, washed, and immediately 
analyzed with a fluorescence plate reader (excitation 368 nm, emission 490 nm). Results 
are expressed as the relative intensity of the zinc signals between treatments. Each 
treatment was replicated in 8-16 wells/experiment, with the average being used to calculate 
statistical differences between experiments. 
Cyclic AMP assay 
Cyclic AMP was measured in cell lysates using a cAMP EIA kit (Cayman 
Chemicals). After isolation, G/T cells were cultured overnight, followed by serum 
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starvation for 72 hr. Cells were treated for 10 min with vehicle, testosterone, mibolerone, 
or TBSA, washed twice with ice-cold PBS, lysed by 20 min incubation with 100 µL 0.1 M 
HCl on ice, then scraped and repeatedly pipetted (20x) to homogenize the suspension. The 
suspension was centrifuged at 1000 x g for 10 min, and the supernatant was diluted 2x and 
assayed immediately. Treatments were conducted in triplicate and data is expressed as 
relative cAMP concentrations. 
Proximity ligation assay 
Interaction of ZIP9 with inhibitory and stimulatory G proteins was assessed in situ 
using a proximity ligation assay (PLA) following the manufacturer’s protocol (Duolink; 
Sigma Aldrich). G/T cells grown on coverslips for 1-2 days were fixed, blocked, and 
incubated with primary antibodies for ZIP9 (mouse 1:200), and Gs (rabbit 1:100) or Gi 
(rabbit 1:100) overnight at 4°C, before continuing the manufacturer’s ligation protocol. For 
co-staining apoptotic cells, G/T cells were treated, fixed, and stained as in the TUNEL 
assay prior to blocking and incubation with primary antibodies for the PLA assay. Stained 
cells were imaged under oil-immersion fluorescence microscopy (100x). Representative 
images were chosen for the presentation of results.  
G protein activation assays 
G protein activation was assessed by measuring [35S]GTPγS binding to G/T cell 
plasma membranes after incubation with 100 nM testosterone or the same volume of 
vehicle (1 µl/100 µl) for 20 minutes at room temperature, using excess GTP to stop the 
reaction, as described previously (121). Membrane-bound [35S]GTPγS was 
immunoprecipitated with specific antibodies for inhibitory (1:100, Gαi 1/2) and stimulatory 
(1:100, Gαs) G proteins or rabbit IgG (1:100; R&D Systems, Minneapolis, MN) using 
protein A/G Plus-agarose beads (Santa Cruz Biotechnology, Inc., Dallas, TX). 
Statistical Analysis 
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All experiments were repeated with G/T cells from a minimum of 3 fish. In 
experiments that examined both early and late stage G/T cells, the two subsets were isolated 
from the same fish. Statistical significance was determined by Student’s t-test or one- or 
two-way ANOVA with a post hoc Bonferroni multiple comparison test. The one-way 
ANOVA was used to analyze experimental results with multiple steroid treatments and 
concentrations. The two-way ANOVA was used to analyze data from the experiments in 
which cells were co-treated with pharmacological drugs and testosterone, underwent 
different siRNA transfections, or when both early and late stage G/T cells were used. All 
data is expressed as the mean ± SEM using GraphPad Prism 5 software (GraphPad 
Software, San Diego, CA). 
RESULTS 
Characterization of ZIP9 in different size follicles 
The actual composition of the early and late stage follicle pools was determined by 
characterizing a subset of follicles from each pool. The early stage size class was primarily 
made up of PNS (75%) and EV follicles (15%), with approximately 10% LV follicles (Fig 
3.1A). The late stage size class consisted of primarily LV follicles (74%), with EV and 
PNS follicles making up 7% and 19%, respectively. ZIP9 mRNA (Fig 3.1B) and protein 
(Fig 3.1C) expression were significantly higher in G/T cells from the early stage follicles 
compared to late stage follicles. The binding of various androgens to the plasma membrane 
fractions of early and late stage follicles was assessed by a single point competitive 
androgen binding assay. In membrane fractions from both stages, [3H]T binding was 
displaceable by unlabeled testosterone but not by mibolerone, a nuclear androgen receptor 
agonist (Fig 3.1D-E). This indicates that an androgen binding site is present on the plasma 
membranes in both follicle stages and that androgen binding is not to the AR. 
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Characterization of testosterone’s effect on survival of G/T cells from early and late 
stage follicles 
To determine the effect of testosterone on survival of G/T cells from early and late 
stage follicles, the incidence of apoptosis, as well as mRNA expression of the pro-apoptotic 
genes bax and p53, was examined. Testosterone significantly decreased the incidence of 
apoptosis compared to vehicle controls in early stage G/T cells but induced apoptosis in 
late stage G/T cells, as determined by TUNEL labeling (Fig 3.2A). The incidence of 
apoptosis was also examined by Hoechst staining (Fig 3.2B), which showed similar trends 
to that of the TUNEL assay, confirming the validity of the Hoechst assay for use in 
apoptosis analysis in subsequent experiments. The testosterone dose-response relationship 
and the androgen specificity of the anti-apoptotic response were examined in early stage 
G/T cells. The anti-apoptotic response showed an inverse dose-dependent relationship with 
10 and 20 nM doses being more potent than 50 and 100 nM at inhibiting apoptosis (Fig 
3.2C). The response was testosterone-dependent, with significantly reduced apoptosis in 
cells treated with free or BSA-conjugated testosterone (TBSA), but not with the nuclear 
androgen receptor agonist mibolerone (Fig 3.2D). The dose and specificity of the apoptotic 
response were not assessed in this study because these measures have previously been 
examined in croaker G/T cells that exhibit testosterone-induced apoptosis (117). The 
mRNA expression of the pro-apoptotic members Bax and p53 was differentially regulated 
by testosterone in G/T cells from early and late stage follicles, with late stage follicles 
showing a significant increase in expression and early stage showing significantly 
decreased expression of both Bax and p53 mRNA (Fig 3.2E-F). 
Role of ZIP9 in the testosterone-mediated anti-apoptotic response 
To determine which androgen receptor mediates the anti-apoptotic response of 
early stage G/T cells, the cells were transfected with siRNA targeting ZIP9 or the AR. The 
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testosterone-mediated anti-apoptotic response was lost after transfection with siRNA 
targeting ZIP9 but not with transfection of AR targeting siRNA (Fig 3.3C-D). Western blot 
analysis of ZIP9 expression in plasma membrane samples verified a significant decrease 
in the targeting siRNA treatment, while the non-targeting control siRNA showed no 
decrease compared to non-transfected control (Fig 3.3A). A similar decrease in expression 
of AR after transfection with AR-targeting siRNA but not non-targeting siRNA was 
confirmed by qPCR (Fig 3.3B). 
Testosterone modulation of intracellular free zinc and Gα signaling 
Previous work has demonstrated that ZIP9 mediates testosterone-induced apoptosis 
by increasing intracellular free zinc levels and by activating a Gs in croaker G/T cells from 
mature ovaries (25,117). Therefore, androgen regulation of intracellular zinc and members 
of the Gs signaling pathway were examined in the ZIP9-mediated anti-apoptotic response. 
Testosterone and TBSA treatment significantly reduced intracellular free zinc levels of 
early stage G/T cells, while mibolerone had no effect (Fig 3.4A). Treatment with the zinc 
chelator TPEN significantly reduced apoptosis compared to no treatment vehicle controls, 
similar to that of testosterone treatment (Fig 3.4B). This indicates that low intracellular 
zinc levels are anti-apoptotic in G/T cells. In early stage G/T cells the Gsα-subunit inhibitor 
NF499 had no effect on the testosterone-mediated anti-apoptotic response (Fig 3.4C), 
indicating the response does not require Gsα activity. Co-treatment of testosterone with 
either the adenylyl cyclase activator forskolin or the cAMP analog 8-Bromoadenosine 
3′,5′-cyclic monophosphate (8-Br-cAMP) abolished the testosterone-mediated anti-
apoptotic response (Fig 3.4D), indicating that Gs-meditated signaling actively antagonizes 
the anti-apoptotic response. Early stage G/T cells treated with testosterone or TBSA 
showed a significant decrease in cAMP levels compared to vehicle, while mibolerone had 
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no effect (Fig 3.4E). This suggests that testosterone may activate an inhibitory G protein 
in early stage G/T cells.  
ZIP9-G protein interactions in early and late stage G/T cells 
A proximity ligation assay (PLA) was used to examine if different G proteins may 
be able to interact with ZIP9 in G/T cells from early and late stage follicles. ZIP9-Gi and 
ZIP9-Gs interactions (>40 nm) were evident in both G/T cell populations, but the intensity 
of the ZIP9-Gi signal was enhanced in early follicle stage G/T cells while in late stage G/T 
cells the ZIP9-Gs signal was more prevalent (Fig 3.5A). Additionally, in testosterone-
treated late stage G/T cells that were TUNEL stained prior to PLA probing, apoptotic nuclei 
were found to co-localize with the ZIP9-Gs interaction (Fig 3.5B). Expression of Gi and Gs 
on the plasma membranes of G/T cells from early and late stage follicles was confirmed 
by Western blot analysis. Both Gi and Gs are expressed in early and late stage follicles, with 
Gi expression significantly higher in early stage G/T cells, and no difference in expression 
of Gs between stages (Fig 3.5C). Next, the activation of Gi and Gs by testosterone was 
examined. Binding of the radiolabeled, non-hydrolyzable, GTP analog GTPγS 
([35S]GTPγS) to the plasma membrane of G/T cells from both early and late stage follicles 
was significantly increased by testosterone treatment, indicating that testosterone activates 
a G protein in G/T cells from each subclass (Fig 3.6A). Membrane-bound [35S]GTPγS from 
G/T cell membranes pre-treated with testosterone was immunoprecipitated with a Gi 
antibody in early stage G/T cells and a Gs antibody in G/T cells from late stage follicles, 
but not with rabbit IgG in either G/T cell subset, demonstrating that testosterone activates 
a Gi in early stage and a Gs in late stage G/T cells (Fig 3.6B-C). 
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DISCUSSION 
This study demonstrates that the zinc transporter ZIP9 acts as a membrane androgen 
receptor to mediate differential survival responses in Atlantic croaker G/T cells in a follicle 
stage-dependent manner. While ZIP9 has previously been reported to elicit apoptosis of 
croaker G/T cells, here we demonstrate that this response can be attributed to G/T cells 
from late stage vitellogenic follicles. In G/T cells from perinuclear and early vitellogenic 
follicles ZIP9-mediates an anti-apoptotic response. We have provided evidence that 
indicates ZIP9 mediates these opposing responses by activating either a stimulatory or 
inhibitory G protein, dependent upon the stage of the ovarian follicle development. 
Although it has been shown that ZIP9 can activate various G proteins in different models, 
this is the first evidence indicating ZIP9 can activate multiple G proteins within a single 
cell model, (25,26,118). Furthermore, the current work highlights that testosterone 
regulates opposite intracellular free zinc responses between early and late stage G/T cells, 
which corresponds to the opposite survival responses mediated by ZIP9 in early and late 
stage G/T cells. The finding that ZIP9 can mediate both survival and apoptotic responses 
in croaker G/T cells depending on the stage of follicular development indicates that the 
receptor may play a critical role in multiple physiological processes essential for 
folliculogenesis and maintaining homeostasis in the ovary of Atlantic croaker.  
Previously, a ZIP9-mediated apoptotic pathway was characterized using G/T cells 
pooled from total follicles present in ovaries of reproductively mature fish (GSI>12). This 
apoptotic pathway was found to involve the activation of a Gs and upregulation of pro-
apoptotic members (25,117), similar to as seen in late stage G/T cells in the current study. 
Atlantic croaker are indeterminate asynchronous spawners that maintain ovarian follicles 
at all stages of development throughout the reproductive season (128), but the majority of 
the volume of reproductively mature ovaries is made up of late vitellogenic follicles (author 
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observation). Thus, in G/T cells pooled from mature ovaries, the larger proportion of late 
stage G/T cells would likely mask any differential phenotypes of the early stage G/T cells. 
It is concluded that the ZIP9-mediated apoptotic response is attributed to the late stage 
follicle G/T cells, and therefore it is assumed that the apoptotic response of these cells 
involves signaling pathways and pro-apoptotic members characterized previously (117). 
Thus, in the current study, the emphasis was placed on the examination of the testosterone-
mediated effects exhibited by the early stage follicle cells.  
Arguably the most important finding of this study is that ZIP9-mediates 
testosterone-induced pro- and anti-apoptotic responses through activation of different G 
proteins and subsequent differential signaling cascades. Previously, the ZIP9-mediated 
apoptotic pathway was characterized as involving Gs-mediated signaling, MAPK activity, 
and a rise in intracellular free zinc (25,117). These signaling events are upstream of 
increases in caspase 3 activity, increased mRNA expression of pro-apoptotic members, and 
cell death by apoptosis. In the current study, the anti-apoptotic response is characterized 
by Gi activation, subsequent decreased cAMP levels, and decreased mRNA expression of 
pro-apoptotic members and apoptosis. Furthermore, the anti-apoptotic response 
downstream of Gi-mediated signaling is antagonized by Gs-mediated signaling as 
demonstrated by the inhibitory effect of an adenylyl cyclase activator or cAMP analog on 
the anti-apoptotic response. In croaker G/T cells, mPRα also mediates an anti-apoptotic 
response through activation of a Gi (24), suggesting that different receptors may be able to 
elicit similar survival or death responses by activation of a Gi or Gs in this model.  
Interestingly, it was found that the effect of testosterone on intracellular free zinc 
levels also differs between early and late stage G/T cells. While the ZIP9-mediated 
apoptotic pathway involves an increase in free intracellular zinc (25), an opposite trend 
was found in early stage G/T cells that exhibit the anti-apoptotic response in the present 
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study. Previously, the rise in intracellular free zinc associated with androgen-induced 
apoptosis in croaker G/T cells was attributed to ZIP9 activity and found to be essential for 
the induction of androgen-induced apoptosis (25). In human breast and prostate cancer cell 
lines, ZIP9-mediated apoptosis also involves an increase in intracellular free zinc that is 
ZIP9-dependent and required for the apoptotic response. Of interest, in the cancer cell lines 
ZIP9 mediates apoptosis by activating a Gi (26). In PC-3 prostate cancer cells 
overexpressing ZIP9 (PC3-ZIP9), the ZIP9-mediated increase in free zinc is pertussis 
toxin-sensitive and can be blocked by the addition of the non-hydrolyzable GTP analog 
GTPγS, indicating that the zinc response is downstream of Gi activation (120). To our 
knowledge, ZIP9 is the only ZIP family member that regulates zinc by G protein activation, 
but its ability to do so has not been examined in the croaker G/T cell model. It is also of 
interest to further examine the testosterone-induced decrease in free intracellular zinc 
exhibited by early stage G/T cells and the role of ZIP9. ZIP family members regulate the 
transport of zinc into the cytoplasmic compartment (95), thus, it is unclear how ZIP9 may 
mediate a reduction in free zinc. One possibility is that the decrease in free zinc is mediated 
by an androgen-dependent inhibition of the zinc transport activity of ZIP9, resulting in 
reduced zinc transport into the cytoplasm from extracellular and subcellular compartments. 
While differential ZIP9-G protein coupling occurs in croaker G/T cells, Gi coupling 
in early stage follicles followed by Gs coupling in late stage follicles, the mechanism 
driving this switch in coupling is unclear. Whereas most G protein-coupled receptors are 
associated with a single class of G proteins, a number of receptors are known to have the 
ability to couple to different classes of G proteins even within a single model. This was 
first documented for the β2-adrenergic receptor (β2-AR) (98) but has further been 
established for other G protein-coupled receptors including the β1-adrenergic, the 
prostacyclin, and vasoactive intestinal peptide receptors (129–131). Similar to the current 
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study, the β2-AR can mediate both pro- and anti-apoptotic responses through activation of 
a Gs and Gi, respectively, in cardiac myocytes (132). The G protein coupling switch 
observed in the β2-AR and prostacyclin receptor models has been attributed to the receptors 
initially coupling to a Gs to promote PKA activity followed by PKA phosphorylation of 
the receptor which reduces Gs and heightens Gi coupling affinities. Thus, in these models 
the Gi coupling is dependent on the Gs-mediated pathway. In the croaker G/T cells, the 
anti-apoptotic effect is unaffected by co-treatment with the Gsα-subunit inhibitor, NF449. 
While this may indicate that the differential coupling of ZIP9 may be through a different 
mechanism to that of the β2-AR and the prostacyclin receptor, it is important to note that 
the studies on the β2-AR and the prostacyclin receptor were done in transfected cell models, 
whereas the differential coupling of ZIP9 in the current model was examined in a primary 
culture system. Thus, desensitization of one G protein may occur in vivo and remain fixed 
through isolation, culturing, and experimentation. Furthermore, early and late stage follicle 
G/T cells have different expression profiles of ZIP9 and the Gi, which may also play a role 
in the regulation of ZIP9-G protein coupling. While the current study does not address the 
mechanism behind this shift in ZIP9-G protein coupling, the fact that ZIP9 can couple to 
multiple G proteins in the current model as well as different G proteins between models 
indicate that ZIP9-G protein interactions should be further examined to determine if the 
receptor can switch G protein coupling in other models.  
Androgens have been found to promote survival and growth as well as death in 
various mammalian and fish ovarian models (54,55,57–64,114–116). These studies 
demonstrate a general trend that androgens promote growth and survival during earlier 
stages of follicle development (54,55,57–59,115,116) and promote apoptosis and atresia in 
both preantral and antral follicles in mammals (60–65,114). It is important to note that in 
many of these studies the role of a specific androgen receptor in mediation of the response 
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was not confirmed. Recently, Lim et al. 2017 demonstrated that the androgen 
dihydrotestosterone (DHT) promotes apoptosis in granulosa cells from rat antral follicles, 
but is protective and promotes proliferation of granulosa cells from preantral follicles. 
Further examination of the anti-apoptotic/proliferative effect attributed it to AR-mediated 
expression of soluble Kit ligand (114). The role of the AR in early stage ovarian follicle 
growth and development is further supported by the AR knockout models which show 
detrimental phenotypes including decreased ovarian follicle growth and increases in atretic 
and apoptotic follicles (68,70–72). In the current study, we found no evidence for a role of 
the AR in the anti-apoptotic response exhibited by early stage croaker G/T cells. The 
nuclear androgen receptor agonist mibolerone, which does not interact with ZIP9 (25), did 
not mimic the effect of testosterone on G/T cell survival. Additionally, siRNA knockdown 
of ZIP9, but not the AR, effectively abrogated the testosterone-mediated anti-apoptotic 
effect. While this may indicate that the mechanism behind the androgen-mediated anti-
apoptotic response differs between rat and croaker models, ZIP9’s role has not been 
examined in androgen-mediated survival of early stage ovarian follicles in any mammalian 
model to date, so its significance in these models remains unclear. In addition, the receptor 
mediating androgen-induced apoptosis in murine (114) and porcine (64,65) antral ovarian 
granulosa cells has not been investigated. We have demonstrated that ZIP9 plays a role in 
androgen-mediated apoptosis of late stage croaker G/T cells that respond to androgens in 
a similar manner to mammalian antral stage granulosa cells (114), but it remains unknown 
if a ZIP9-mediated mechanism is involved in the mammalian models. Overall, the 
discovery of a novel membrane androgen receptor, ZIP9, highlights the need to re-examine 
the receptor mediating androgen-mediated responses that were previously attributed to the 
AR without loss of function verification in the ovary and other tissues that are androgen 
receptive.  
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The ability of ZIP9 to mediate both survival and death responses in an ovarian 
follicle stage-dependent manner may be a means of regulating the fate of individual 
follicles within the ovary. Androgens have been shown to be present in the plasma 
throughout the reproductive season of a number of teleosts, including members of the 
Sciaenidae family of which Atlantic croaker is a member (133). Thus, it may be of benefit 
for a stimulus that is present throughout folliculogenesis, to have the ability to induce 
differential responses depending on the developmental stage of the ovarian follicle. This 
may be especially important in an asynchronous spawning teleost such as the Atlantic 
croaker, which can have follicles of all developmental stages present in the ovary 
throughout the reproductive season (128). In this way, testosterone may act as a protective 
factor in follicles undergoing early growth and vitellogenesis, and an apoptotic factor in 
follicles at later stages of development. The physiological relevance of androgen-induced 
apoptosis in late stage ovarian follicles is unclear. However, apoptosis is involved in the 
removal of atretic follicles in both teleosts and mammalian ovaries, as well in the regression 
of mammalian corpus luteum and post-ovulatory follicle in teleost (81,83–85). Of interest, 
upregulation of ZIP9 and members of the ZIP9-mediated apoptotic pathway were 
associated with impaired oogenesis and increased ovarian apoptosis and atresia in Atlantic 
croaker exposed to the environmental stressor hypoxia (134). Thus, ZIP9-mediation of 
survival and death responses may also allow for the adjustment of the recruited ovarian 
follicle reserve in response to environmental stressors and stimuli. However, further work 
investigating the mechanism mediating the switch in ZIP9-G protein coupling is required 
to determine this. 
In conclusion, the present study demonstrates that the novel membrane androgen 
receptor ZIP9 can mediate opposite survival responses in Atlantic croaker G/T cells by 
differentially activating a Gi and Gs. ZIP9-G protein interaction is follicle stage-dependent, 
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with ZIP9 activating a Gi to elicit a survival response in early stage follicle G/T cells, while 
ZIP9 activation of a Gs mediates apoptosis of late stage G/T cells. This is the first evidence 
that ZIP9 can mediate different physiological responses by activating multiple G proteins 
in a single model. Although the physiological relevance of the pro- and anti-apoptotic 
responses was not investigated in the current study, the ability of a single receptor to elicit 
opposing responses at different developmental stages may be a mechanism that allows for 
more precise control of folliculogenesis in the dynamic ovarian environment. ZIP9 is 
expressed in the majority of croaker and human tissues examined, but knowledge on ZIP9’s 
role in meditation of androgen-induced responses in vertebrates is greatly lacking. 
Additional studies on the role of ZIP9 in the ovary of teleosts as well as higher vertebrates 
will provide insight into the role of the receptor in ovarian physiology. Our current findings 
indicate that ZIP9 possesses unique characteristics that warrant further investigation in a 
wide range of vertebrate models. 
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FIGURES 
 
Figure 3.1: Characterization of follicle classes and ZIP9 in early and late stage ovarian 
follicles. A, Relative composition of early and late stage follicle classes. B-C, mRNA (B) 
and membrane protein (C) expression of ZIP9 in G/T cells from early and late stage 
follicles. D-E, Displacement of membrane-bound [3H]T by various androgen in early (D) 
and late (E) stage follicles, expressed as percentage of maximal [3H]T binding. All data 
represents means ± SEM, n=3-4 (A-C), n=9 (D, E). Significance was determined by 
Student’s t-test (B, C; **, p<0.01) or one-way ANOVA with Bonferroni multiple 
comparison post-test (D, E). Different letters indicate significant differences between the 
treatment groups in the post hoc test at p < 0.05. Follicle class distribution and ZIP9 
expression analyses were conducted with 3-4 fish. For binding experiments, each treatment 
was conducted in triplicate with similar results obtained for each, and the experiments were 
repeated with 3 fish. PNS, perinuclear stage; EV, early vitellogenic stage; LV, late 
vitellogenic stage; E, early stage; L, late stage; V, ethanol control; T, testosterone; M, 
mibolerone. 
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Figure 3.2: Effect of testosterone on apoptosis and expression of pro-apoptotic members 
in early and late stage G/T cells. 
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Figure 3.2 (continued): Effect of testosterone on apoptosis and expression of pro-apoptotic 
members in early and late stage G/T cells. A-B, Effect of testosterone on apoptosis of G/T 
cells from early and late stage follicles as determined by TUNEL staining (A) and Hoechst 
staining (B). C, Effect of various concentrations of testosterone on % apoptotic nuclei as 
determined by Hoechst staining. D, Effects of androgen treatments on % apoptotic nuclei 
as determined by Hoechst staining. E-F, Expression of bax (E) and p53 (F) mRNA after 24 
hr testosterone treatment of late and early stage G/T cells. All data represents means ± 
SEM, n=6-9 (A-D), n=12 (E, F). Significance was determined by one- (C-D) or two-way 
(A-B) ANOVA followed by Bonferroni multiple comparison post-test, or by Student’s t-
test (E-F). Different letters indicate significant differences between the treatment groups in 
the one-way ANOVA post hoc test at p < 0.05. Level of significance between vehicle and 
testosterone treatments as determined by Student’s t-test or the two-way ANOVA post hoc 
are indicated as *, p<0.05; **, p<0.01; ***, p<0.001. In experiments A-B, significant 
interactive effects of testosterone treatment on G/T cell survival between early and late 
stage cells was detected by the two-way ANOVA, which was predicted because early and 
late stage G/T cells show differential responses to testosterone. Incidence of apoptosis 
experiments (A-D) were repeated with three fish and each treatment conducted in duplicate 
or triplicate with similar results obtained for each. Pro-apoptotic member mRNA 
expression analyses (E-F) were repeated with 6 fish and each treatment conducted in 
duplicate. M, mibolerone; TBSA, testosterone-BSA. 
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Figure 3.3: Effect of ZIP9- and AR-targeting siRNA on the testosterone-induced anti-
apoptotic response of early stage G/T cells. A-B, ZIP9 protein (A) and AR mRNA (B) 
expression after transfection with targeting and non-targeting siRNA. C-D, Effect of 
siRNA targeting ZIP9 (C) or AR (D) on the testosterone-induced anti-apoptotic response. 
All data represents means ± SEM, n=3 (A-B) n=6 (C-D). Significance was determined by 
one- (A, B) or two-way (C, D) ANOVA followed by Bonferroni multiple comparison post-
test. Different letters indicate significant differences between the treatment groups in the 
one-way ANOVA post hoc test at p < 0.05. Level of significance between vehicle and 
testosterone treatments as determined by the two-way ANOVA post hoc are indicated as 
*, p<0.05; **, p<0.01; ***, p<0.001. In experiment (C) but not (D), significant interactive 
effects of the steroid treatment (V & T) and the transfection treatments on G/T cell 
apoptosis was detected by the two-way ANOVA, which was predicted because ZIP9-
targeting siRNA blocked the testosterone-induced responses, while AR-targeting siRNA 
did not. Experiments were repeated with three fish and each treatment conducted in 
duplicate with similar results obtained for each. NT, no transfection; Ctl, non-targeting 
siRNA control; siRNA, small interfering RNA. 
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Figure 3.4: Effects of testosterone on components of the ZIP9-mediated apoptotic 
signaling pathway in early stage G/T cells.  
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Figure 3.4 (continued): Effects of testosterone on components of the ZIP9-mediated 
apoptotic signaling pathway in early stage G/T cells. A, Effect of various androgens on 
intracellular free zinc levels. B, Effect of the zinc chelator TPEN on G/T cell apoptosis. C, 
Effect of Gsα inhibitor NF449 on the anti-apoptotic effect of testosterone. D, Effects of 8-
Br-cAMP and forskolin on the anti-apoptotic response to testosterone. E, Relative cAMP 
concentrations in early stage G/T cells treated with various androgens for 10 min. All data 
represents means ± SEM, n=4 (A), n=6 (B, C, D), n=9 (E). Significance was determined 
by one- (A, B, E) or two-way (C-D) ANOVA with Bonferroni multiple comparison post-
test. Different letters indicate significant differences between the treatment groups in the 
one-way ANOVA post hoc test at p < 0.05. Level of significance between vehicle and 
testosterone treatments as determined by the two-way ANOVA post hoc are indicated as 
*, p<0.05; **, p<0.01. In experiment (D), significant interactive effects of testosterone 
treatment in the presence of the pharmacological agents on G/T cell survival was detected 
by the two-way ANOVA, which was predicted because 8-Br-cAMP and forskolin 
effectively blocked the testosterone-mediated response. In experiment (C), no interaction 
was found between testosterone treatment and the presence of the Gsα inhibitor. 
Intracellular zinc was assessed in 4 fish, experiments (B-E) were repeated with 3 fish and 
each treatment conducted in duplicate or triplicate with similar results obtained for each. 
M, mibolerone; TBSA, testosterone-BSA; TPEN, N,N,N’,N’-tetrakis(2-pyridylmethyl)-1 
,2-ethylenediamine; Gsα inhib., NF449; 8-Br-cAMP, 8-bromoadenosine 3′,5′-cyclic 
monophosphate. 
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Figure 3.5: Interaction of ZIP9 with Gi and Gs in G/T cells from early and late stage 
follicles. 
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Figure 3.5 (continued): Interaction of ZIP9 with Gi and Gs in G/T cells from early and late 
stage follicles. A. Representative images of ZIP9-Gi and ZIP9-Gs interactions in G/T cells 
from early and late stage follicles as indicated by red signal in the in situ proximity ligation 
assay. B, Representative images of co-localization of testosterone-induced apoptotic nuclei 
(green, indicated by white arrows) with ZIP9-G protein interactions in late stage G/T cells. 
C, Relative expression of Gi and Gs in early and late stage G/T cells. Data represents means 
± SEM, n=3 (A, B), n=5 (C). Significance was determined by Student’s t-test. *, p<0.05. 
Experiments were repeated with cells from 3-5 fish with similar results obtained for each. 
E, early stage; L, late stage. 
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Figure 3.6: Testosterone activation of 
G proteins in G/T cells from early and 
late stage follicles. A, Effect of 20 min 
testosterone treatment on specific 
[35S]GTPγS binding to plasma 
membranes of G/T cells from early and 
late stage follicles. B-C, 
Immunoprecipitation of testosterone-
induced [35S]GTPγS binding to early 
stage (B) or late stage (C) G/T cell 
membranes with specific Gi and Gs 
antibodies or rabbit IgG control. All 
data represents means ± SEM, n=12-15 
(A), n=3 (B, C). Significance was 
determined by Student’s t-test. *, 
p<0.05; **, p<0.01; ***, p<0.001. 
Experiments were repeated with 3-4 
fish and with similar results obtained 
for each. 
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SUPPLEMENTAL DATA 
 
 
Table 3.1: Sequence of primers (5’-3’) used for qPCR experiments (Chapter 3). 
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Chapter 4:  Evidence that ZIP9 regulates both G/T cell apoptosis and 
oocyte activation in the zebrafish ovary 
ABSTRACT 
The novel membrane androgen receptor ZIP9 mediates androgen-induced 
apoptosis in Atlantic croaker ovarian granulosa and theca (G/T) cells, however, its role in 
the ovarian physiology of other teleosts is unknown. In this study, the role of ZIP9 in the 
zebrafish ovary was investigated using primary G/T cell culture and global ZIP9 knockout 
models. Zebrafish ovaries highly expression ZIP9 mRNA and possess a testosterone-
specific binding site on membrane fractions. Testosterone induces an apoptotic response 
in zebrafish G/T cells that is blocked with ZIP9-targeting siRNA. Testosterone treatment 
also increases caspase 3 activity, expression of pro-apoptotic member p53 and Bax mRNA, 
and a rapid rise in free intracellular zinc. The similarity of the ZIP9-mediated apoptotic 
pathways in zebrafish and croaker G/T cells suggest this response may be conserved in 
teleosts. Global ZIP9 knockout using a CRISPR-Cas9 system resulted in reduced female 
fecundity, with significantly fewer spawned eggs and lower fertilization rates compared to 
wild-type controls. In addition, ZIP9 knockout females produced eggs that did not undergo 
chorion elevation, which normally occurs during egg activation. Eggs displaying the non-
activated phenotype showed very low fertilization rates and larvae with high levels of 
pericardial/yolk sac edema and reduced growth compared to larvae hatched from wild-type 
or normal phenotype ZIP9 knockout eggs. In conclusion, the severe impairment of 
reproductive capacity and the associated non-activated egg phenotype observed in ZIP9 
knockouts suggest that in addition to the role of ZIP9 in mediating apoptosis in vitro, the 
receptor may also play a role in egg activation in vivo.  
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INTRODUCTION 
Recently, a putative membrane androgen receptor cloned in Atlantic croaker 
ovaries was found to be homologous with zinc transporter protein ZIP9, the lone member 
of the SLC39A subfamily I (25). In the croaker ovary, ZIP9 mediates both testosterone-
induced apoptosis and survival of granulosa and theca (G/T) cell co-culture by activating 
G proteins, which results in rapid signaling events and downstream regulation of pro-
apoptotic member mRNA expression and caspase 3 activity (117). Interestingly, androgen 
activation of ZIP9 also results in regulation of intracellular free zinc levels in croaker G/T 
cells indicating that the zinc transport functions of ZIP9 are androgen-sensitive, which is 
unique to this zinc transporter (25). Furthermore, ZIP9 has recently been found to mediate 
apoptosis in human cancer cell lines (26), tight junction formation in murine Sertoli cells 
(118), and migration of human glioblastoma cell lines (119). While these initial studies 
demonstrate several sites of action and functions of ZIP9, we currently have a limited 
understanding of the functions of this novel membrane androgen receptor and zinc 
transporter in animal physiology.  
In croaker ovaries, ZIP9 protein expression varies throughout the reproductive 
season with expression being undetectable in regressed ovaries (gonado-somatic index ~0), 
and dramatically increased in recrudescent and reproductively mature ovaries (25). 
Furthermore, ovarian ZIP9 protein expression can be regulated by reproductive hormones 
ex vivo (25). Thus, the changes observed in the expression of the receptor in vivo 
throughout the reproductive season and the ability for hormones to mediate expression ex 
vivo suggest a role for ZIP9 in croaker ovarian physiology. Androgens are known to 
regulate a number of physiological processes in the ovary, many of which have been 
attributed to activation of the nuclear androgen receptor (AR) in both murine and zebrafish 
knockout models. Murine and zebrafish AR knockouts show subfertility with premature 
 76 
ovarian failure (69,135), decreased expression of aromatase (cyp19a1) mRNA expression 
in the ovary (70,135), and decreased litter sizes or fewer ovulated oocytes, in murine (68–
70) and zebrafish models (136), respectively. However, many androgen-mediated actions 
have not been directly attributed to the AR through the use of knockout models. 
Additionally, the limited work on the role of ZIP9 actions in the ovary and the novelty of 
its identification as a membrane androgen receptor, indicate a need for further evaluation 
of mechanisms of androgen action in the ovary to determine the relative importance of the 
AR and ZIP9 in androgen regulation of ovarian physiology. 
Zinc signaling has also recently been shown to have a role in ovarian physiology. 
In mammals, zinc has been found to mediate events in periovulatory oocytes and those 
undergoing maturation and activation. Zinc is the most prominent transitional metal 
detected in late stage oocytes and is actively accumulated during maturation and the 
resumption of meiosis (germinal vesicle breakdown (GVBD) to metaphase II (MII) arrest) 
(137). Furthermore, a zinc “spark”, or rapid release of zinc to the extracellular space, has 
been shown to accompany the fertilization-induced wave of free intracellular Ca++ in 
mammalian eggs (138). In murine periovulatory oocytes, zinc has also been found to be 
involved in meiotic arrest, and zinc chelation and dietary deficiency induce resumption of 
meiosis but with abnormal spindle configurations resulting in the inability to reach 
metaphase II (139). An increase in oocyte zinc content has also been observed in the 
transition of zebrafish oocytes from previtellogenic to late vitellogenic stages (140), and 
the zebrafish ovary expresses the widest variety of zinc transporters compared to various 
non-reproductive tissues (141). However, the role of zinc signaling in ovarian and oocyte 
physiology in fish has not been extensively investigated to date. 
While the role of ZIP9 in ovarian granulosa/theca cells has been extensively studied 
in Atlantic croaker, it is unknown if ZIP9 mediates androgen actions in G/T cells of other 
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teleosts. The current study looks to further the understanding of ZIP9 in teleost ovarian 
physiology by investigating the role of the receptor in the ovary of zebrafish. First, using a 
primary zebrafish G/T cell culture model, we confirmed that ZIP9 meditates testosterone-
induced apoptosis in zebrafish G/T cells similar to that observed in croaker G/T cells. Next, 
a global ZIP9 knockout model was developed using a CRISPR-Cas9 system in order to 
examine the role of ZIP9 in female reproduction. Effects on reproduction were determined 
by comparing fecundity, larval health and growth, and ovarian morphology between ZIP9 
wild-type and mutant fish.  
MATERIALS AND METHODS 
Chemicals and materials 
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
stated. Testosterone and 4-estren-7α, 17α-dimethyl-17β-ol-3-one (Mibolerone) were 
purchased from Steraloids (Newport, RI). [1,2,6,7-3H]Testosterone ([3H]T) (100 Ci/mmol) 
was purchased from American Radiolabeled Chemicals (St. Louise, MO). Bovine serum 
albumin-conjugated testosterone (TBSA) was dialyzed to remove free testosterone by 
incubation with 5 mg/ml charcoal and 0.5 mg/ml dextran at 55°C under gentle rotation for 
30 min followed by removal of the charcoal by two centrifugation cycles at 4600 x g for 
20 min each.  
Zebrafish husbandry 
Wild-type zebrafish (Danio rerio) were obtained from Segrest Farms (Gibsonton, 
FL, USA) and maintained in a 14 hr light:10 hour dark cycle at 28.5°C at the University of 
Texas Marine Science Institute in Port Aransas, TX. Adult fish were fed 1-2 times a day a 
mixed diet of commercial flakes, pellets, and live brine shrimp. Larvae (5-10 dpf) were fed 
boiled egg yolk, and juvenile fish were fed live brine shrimp, twice daily. For tissue 
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collection, fish were deeply anesthetized by immersion in a bath containing 20 mg/L MS-
222 and humanely euthanized by rapid decapitation in accordance with procedures 
approved by the University of Texas Animal Care and Use Committee. 
Primary granulosa/theca cell culture 
Ovarian tissue from 7-15 reproductively mature females with high GSI’s (12-20%, 
high proportion of mid and late stage follicles) was pooled, and G/T cell isolation was 
performed following a modified protocol previously described for Atlantic croaker 
(Micropogonias undulatus) G/T cell isolation (96). Briefly, ovarian tissue was placed into 
Ca/Mg-free buffer (138 mM NaCl, 8.6 mM KCl, 1.62 mM Na2HPO4, 5 mM D-glucose, 
15.8 mM HEPES, 1 mM EDTA, 100 mg/L streptomycin, 60 mg/L penicillin, pH 7.4), 
repeatedly pipetted to separate ovarian follicles, and enzymatically digested with 0.1% 
collagenase for 1 hr at room temperature. After digestion, G/T cells were sheared from the 
follicles by repeated pipetting, then the supernatant was passed through a 70 µm filter and 
centrifuged at 500 x g for 10 min. The cell pellet was resuspended in M199 media (Earle’s 
salts with L-glutamine; Gibco, Waltham, MA), layered onto a 4.5% Percoll pad, and 
subsequently centrifuged at 2800 x g for 20 min. The G/T cell layer between the Percoll 
pad and media was removed, and the G/T cells were washed once with media to remove 
the Percoll. G/T cells were plated and grown in MI99 media containing 10% charcoal-
stripped FBS in a 5% CO2 humidified incubation chamber at 28°C. All culture media 
contained the aromatase and p450 side chain cleavage inhibitor DL-Aminoglutethimide 
(100 µM) (Alfa Aesar, Ward Hill, MA). For siRNA and expression plasmid transfections, 
zebrafish G/T cells were transfected with a mixture of siRNA primers targeting the 5’ 
untranslated region of ZIP9 mRNA sequence (Dharmacon, Lafayette, CO), control siRNA 
primers (Dharmacon), a zebrafish-ZIP9 open reading frame (ORF) expression plasmid 
(Genscript, Piscataway, NJ), or both the ZIP9-targeting siRNA and expression plasmid. 
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Transfection was performed upon initial plating, and media was changed after 16 hr. All 
treatments were performed 72 hours after transfection. 
mRNA isolation and qualitative real-time PCR analysis 
Total mRNA was isolated using Tri-reagent (Sigma-Aldrich) following the 
manufacturer's protocol. For examining the effects of testosterone on the expression of pro-
apoptotic genes, G/T cells were starved for 16-24 hrs followed by treatment with 
testosterone (50nM) or ethanol vehicle for 24 hr prior to mRNA isolation. Qualitative real-
time PCR (qPCR) primers were designed against the mRNA sequences of ZIP9, bax, and 
p53 (Table 4.1). qPCR was performed using Verso 1-step RT-qPCR SYBR Green Low 
ROX kit (Thermo Scientific, Waltham, MA), with 50 ng of mRNA per 15 µL reaction, 
following the manufacturer’s protocol. The qPCR program was as follows, 50°C for 15 
min, 95°C for 15 min, and 40 cycles of 95°C for 15 s, 55°C for 30 s, 72°C for 30 s. 
Amplification was followed by the melting curve program, 95°C for 15 s, 60°C for 15 s 
and a gradual increase to 95°C over 20 min. Samples were run in duplicate and expression 
was normalized to the housekeeping gene 18S. 
Membrane protein preparation  
All steps were carried out at 4°C. Ovarian tissue was homogenized in ice-cold 
HAED buffer (25 mM HEPES, 10 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.6) 
containing protease inhibitor (1µl/ml), followed by centrifugation at 1000 x g for 7 min to 
pellet the nuclear fraction. The supernatant was removed and centrifuged at 20000 x g for 
20 min to pellet the membrane protein fraction. For Western blot analyses the membrane 
protein pellet was resuspended in HAED, 5X reducing sample buffer (Thermo Fisher 
Scientific, Waltham, MA) was added, samples were boiled for 8 min, and stored at -80℃ 
until analysis. For the androgen receptor binding assay, the membrane protein pellet was 
resuspended in HAED buffer with protease inhibitor.  
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Membrane androgen receptor binding assay 
The ability of non-labeled testosterone and other steroid competitors to displace 
[3H]T binding to the membrane fractions of ovarian follicles in three-point (T) and single-
point (P4, E2, Mibolerone) competitive binding assays was assessed using methods 
described previously (74). Membrane protein (0.3-0.7 mg/ml final) was added to 5 nM 
(final) [3H]T in the presence of vehicle, 0.01-1 µM unlabeled testosterone, or various 
steroid hormones (100 nM). Nonspecific binding was determined in the presence of 1000x 
unlabeled testosterone (5 µM) and subtracted from total binding to determine specific 
[3H]T binding. Reactions were conducted in triplicate, and the results are displayed as 
displacement of specific [3H]T binding. 
Apoptosis analyses 
Zebrafish G/T cells grown on round glass coverslips were serum-starved for 16-24 
hr prior to the addition of testosterone treatment for 24 hours. All treatments were 
performed in duplicate or triplicate. For Hoechst staining, after treatment, the cells were 
fixed in 4% paraformaldehyde for 20 min at room temperature, stained with 1µg/ml 
Hoechst 33342 for 3 min, rinsed with PBS, and mounted face down on microscope slides. 
Apoptotic nuclei were identified based on the morphology of chromatin under fluorescent 
microscopy, and % apoptotic cells was determined by examination of 400 cells from each 
slide. For TUNEL staining, cells were fixed and stained following the manufacturer’s 
protocol (In Situ Cell Death Detection Kit; Roche, Indianapolis, IN). Apoptosis was 
assessed as fluorescent staining of the nuclei, and % apoptotic cells was determined by 
examination of 600-1200 cells total from a minimum of 4 frames of view (10x) for each 
coverslip.  
Caspase 3 activity assay 
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Zebrafish G/T cells grown in 6-well plates were serum starved for 16-24 hours, 
followed by testosterone treatment (50 nM) for 24 hr, harvested, and caspase 3 activity was 
determined using a Caspase Glo 3/7 Assay kit (Promega, Madison, WI) according to the 
manufacturer’s protocol. Briefly, after treatment, cells were scraped and added in a 1:1 
volume to Caspase-Glo reagent in a white-walled 96-well microplate. The luminescence 
of each sample was immediately analyzed by plate reader (CLARIOstar; BMG Labtech, 
Cary, NC) and subsequent readings were taken every 3 min until values began to drop. The 
highest luminescence value obtained for each sample was used and expressed relative to 
control values. Each treatment was conducted in triplicate, and the experiment was 
repeated three times.  
Intracellular free zinc assay 
G/T cells were grown in 96-well plates for 3-4 days. Cells were serum starved for 
30 min followed by testosterone (50 nM) treatment for 30 min. Cells were fixed with 4% 
paraformaldehyde for 25 min at 4°C, stained with 10 µM zinquin ethyl esther (Enzo Life 
Sciences, Inc., Farmingdale, NY) for 30 min, washed with PBS, and immediately analyzed 
with a fluorescence plate reader (excitation 368 nm, emission 490 nm). Results are 
expressed as the relative intensity of the zinc signal compared to control. Each treatment 
was replicated in 8 wells/experiment, with the treatment average being used to calculate 
statistical differences between experiments.  
Western blot analysis 
Electrophoresis was performed on whole cell lysate or plasma membrane protein 
samples loaded on a 10% SDS-PAGE gel. Protein samples were transferred to a 
nitrocellulose membrane, blocked with 5% nonfat milk for 1 hr, and incubated with 
primary antibodies for ZIP9 1:2000 (custom polyclonal (26)) or actin 1:2000 (Thermo 
Scientific) overnight at 4°C. After incubation, membranes were washed 3 times with PBS 
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(NaCl 137 mM, KCl, 2.7 mM, Na2HPO4 10mM, KH2PO4 1.8 mM) followed by incubation 
with secondary antibodies (1:15000) for 1 hr at room temperature. Protein bands were 
visualized using Odyssey infrared imaging system (LI-COR, Lincoln, NE). 
Design of ZIP9-targeted CRISPR-Cas9 system and gRNA preparation 
Targets for ZIP9 mutagenesis were determined using CRISPOR 
(http://crispor.tefor.net/). The target sequence GAAGGAGTGGTGAGACCCAG in exon 
3 was selected for its high specificity and efficiency scores. Synthesis of guide RNA 
(gRNA) was performed using the methods described in the supplemental protocol for 
Gagnon et al. 2014 (142). Briefly, an oligonucleotide containing a T7 promoter sequence, 
the target sequence, and a complementary region, was annealed to an oligonucleotide 
encoding the reverse-complement sequence of the tracrRNA tail, and the single-stranded 
DNA overhangs filled by the addition of Phusion high-fidelity PCR master mix (Thermo 
Scientific) using the thermocycler program 98°C for 2 min, 50°C for 10 min, and 72°C for 
10 min. The product was directly used for generation of gRNA using a MAXIscript Kit 
(Ambion, Foster City, CA). The gRNA was DNase treated, purified by ethanol 
precipitation, verified for correct length on an agarose gel, and stored at -80°C until use. A 
stop codon cassette containing a stop codon in every reading frame with arms on either 
side homologous to the CRISPR-Cas9 system cut site on exon 3 was designed (adapted 
from (142)) and purchased as oligonucleotides from Invitrogen (Carlsbad, CA). 
Oligonucleotides used in gRNA generation and the stop codon cassette design are listed in 
Table 4.2. 
Establishment of zebrafish ZIP9 mutant strain 
To generate global ZIP9 mutants, an injection mixture containing 0.5 µl 1X Cas9 
NLS (New England Biolabs, Ipswich, MA), 0.3 µl gRNA (1 µg/µl), 0.3 µl stop codon 
cassette oligonucleotide (3 µM), 0.25 µl phenol red, and 1.32 µl nuclease-free water was 
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incubated for 5 min at room temp and then stored on ice until use in embryo microinjection. 
Fertilized eggs were collected within 10 minutes of natural spawning of wild-type (WT) 
fish, and 2 nl of injection mixture was injected into the one-cell stage embryo using a 
micromanipulator (Narishige, Amityville, NY) and microinjector (Tritech Research, Inc., 
Los Angeles, CA). At 4-days post fertilization (dpf), fish underwent fin clipping as 
previously described (143) and the HotSHOT method (144) was used to isolate genomic 
DNA. Isolated DNA was used in PCR to screen for the presence of the stop codon cassette, 
and a heteroduplex mobility assay (HMA) (protocol adapted from (145)) was used for 
mutation detection. Primers used for screening and representative images of mutation 
screening assays can be found in Table 4.3 and Supplemental Figure 4.1, respectively.  
To generate a germline mutation line, a male founder (F0) heterozygous for the 
knock-in of the stop codon cassette in exon 3 was raised to adulthood and mated with WT 
females to obtain F1 offspring. Heterozygous F1 fish were crossed to obtain sibling F2 
ZIP9 homozygous wild-type (ZIP9 +/+), homozygous mutant (ZIP9 -/-), and heterozygous 
fish (ZIP9 +/-). Sibling F2 fish were used for the fecundity analysis, while F3 homozygous 
offspring were used for oocyte, embryo, and ovarian histology studies.  
Fecundity analyses 
Four-month-old F2 ZIP9 +/+ and ZIP9 -/- fish were used for fecundity measures. 
ZIP9 +/+ and ZIP9 -/- fish were mated with breeding-confirmed WT fish. Females were 
acclimated to the breeding tank overnight, and the male was added at in the morning within 
15 min of light on. Fish were left undisturbed for 2 hours and then removed from the tanks, 
and verification of spawning and egg analyses were performed. All measures were 
determined from 5 males/5 female ZIP9 +/+, and 5 male/4 female ZIP9 -/-, which were each 
spawned twice with a 4-day rest between events. Spawning incidence was determined as 
the percentage of spawning in two independent events for each individual ((number of 
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times spawned/2) x 100) (n=4-5). The number of fertilized and unfertilized eggs was 
determined by visualization under a dissecting microscope. Eggs were considered 
unfertilized if they were opaque, but it should be noted that at 2 hrs post spawning, 
unfertilized eggs and those that failed to divide properly are indistinguishable. Percentage 
fertilization for each fish was determined as fertilized eggs/total eggs spawned x 100, and 
reported for each spawning event (n=8-10). Chorion diameter was measured from images 
taken with a dissecting microscope, and the number of eggs with regular and small chorion 
diameters were counted and presented as a percentage of the total eggs released in a 
spawning event (n=8-10).  
Embryo and larval assessments 
The growth of fish through the embryo and larval stages was assessed on F3 ZIP9 
+/+ and ZIP9 -/- fish. Embryos from regular and small diameter chorions were separated 
before hatching so that the growth and incidence of edema could be assessed for the two 
phenotypes separately. All length measurements were assessed by orientating 
unanesthetized (3-10dpf) or anesthetized (10+ dpf) fish eye-over-eye in 3% methyl 
cellulose (Sigma-Aldrich) followed by imaging with a dissecting microscope. A minimum 
of 7 ZIP9 +/+ and ZIP9 -/- (regular chorions) fish from two separate spawning events were 
assessed at each time point (n=15+). ZIP9 -/- fish from small chorions were harder to obtain 
due to high mortality, so limited growth measures were performed and an n<15 was 
obtained for a number of time points. Yolk sac depletion was determined by measuring the 
area (mm2) of the yolk sac of ten 3 dpf fish from 2 separate spawning events using ImageJ 
software (n=20). The incidence of pericardial and yolk sac edema was determined by 
visualization under a dissecting microscope. Embryos from 4-5 spawning events were 
separated by phenotype (regular and small chorions for mutant fish) and assessed at 6 dpf 
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for incidence of edema ((number of fish showing edema/total number of fish) x 100) (n=4-
5). 
Morphological and histological analyses 
Morphological and histological analyses were performed on ~3 month old, 
breeding-confirmed, F3 WT and mutant females. Fish were euthanized using MS-222, after 
which body length, total mass, and ovarian mass were measured. The gonado-somatic 
index (GSI) was calculated as ovarian mass/total mass x 100. Ovarian tissue was fixed in 
4% paraformaldehyde for ~24 hrs. Dehydration, embedding, deparaffinization, sectioning, 
and hematoxylin and eosin staining for histological analysis was performed by Pacific 
Pathology, Inc. (San Diego, CA). Ovarian follicle stage identification using the histological 
preparations was performed by referencing prior works (146,147). 
Statistical Analysis 
All in vitro experiments using G/T cells were repeated a minimum of 3 times. 
Fecundity analyses were performed on 4-5 fish of each sex/strain. Embryo growth was 
determined at each time point from a minimum of 15 fish total, from 2 separate spawning 
events. Statistical significance was determined by Student’s t-test or one- or two-way 
ANOVA with a post hoc Bonferroni multiple comparison test. All data is expressed as the 
mean ± SEM using GraphPad Prism 5 software (GraphPad Software, San Diego, CA). 
RESULTS 
ZIP9 mRNA tissue distribution and androgen binding to zebrafish ovarian plasma 
membranes 
ZIP9 mRNA was expressed in all tissues examined with expression in the ovary 
being significantly higher than all other tissues (Figure 4.1A). When gonadal tissues were 
excluded from the analysis, no significance in the expression of ZIP9 in heart, gill, liver 
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and brain tissues was observed (Figure 4.1B). [3H]T binding to the plasma membrane 
fraction of ovarian fragments was displaceable by unlabeled testosterone in a dose-
dependent manner over the range of 0.01 to 1 µM, but no displacement was observed by 
incubation with 0.1 µM progesterone (P4), estradiol (E2), or the AR agonist mibolerone 
(Figure 4.1C). This indicates there is an androgen binding site on the membrane that is 
specific to testosterone and not mediated by the AR.  
Effects of testosterone on known members of the ZIP9-mediated apoptotic pathway 
To examine the effects of testosterone on signaling and apoptotic members that are 
known to be regulated by ZIP9 in other models (25,26,117), apoptosis, caspase 3 activity, 
mRNA expression of pro-apoptotic members, and intracellular free zinc levels were 
examined in testosterone-treated zebrafish G/T cells. Treatment with 100 nM testosterone 
and bovine serum albumin-conjugated testosterone (TBSA) significantly increased the 
incidence of G/T cell apoptosis compared to control, while 100 nM mibolerone had no 
significant effect (Figure 4.2A). Testosterone treatment (50 nM) also resulted in a rise in 
relative caspase 3 activity and the mRNA expression of pro-apoptotic members Bax and 
p53 (Figure 4.2B,C). Furthermore, testosterone treatment (50 nM) led to a rapid rise (30 
min) in intracellular free zinc compared to vehicle control (Figure 4.2D). 
Role of ZIP9 in testosterone-induced apoptosis 
To determine the role of ZIP9 in the mediation of testosterone-induced apoptosis, 
G/T cells were transfected with siRNA targeting ZIP9 and a ZIP9 expression plasmid. 
Transfection with siRNA targeting ZIP9, but not control siRNA, resulted in a loss of the 
testosterone-induced apoptotic response (Figure 4.3A). Furthermore, the loss of the 
apoptotic response was restored when G/T cells were co-transfected with a ZIP9 ORF 
expression plasmid. Western blot analysis of ZIP9 protein expression confirmed that ZIP9 
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protein was significantly decreased in ZIP9-targeting siRNA transfected cells, but restored 
in cells co-transfected with the expression plasmid (Figure 4.3B). 
Establishment of ZIP9 knockout mutant zebrafish strain 
Embryos obtained after microinjection of the CRISPR-Cas9 system were fin-
clipped at 4 dpf and screening was performed to calculate the rate of mutation. 34% of the 
fish were found to carry the stop codon cassette. Heteroduplex mobility assays found that 
71% of fish had a mutation in exon 3. This indicates that the CRISPR-Cas9 system had a 
relatively high efficiency in producing double strand break-induced mutations, but the 
knock-in of the stop codon cassette was less efficient. In addition, all fish possessing the 
stop codon cassette were found to be genetically mosaic at exon 3. Therefore, a male fish 
possessing a single copy of the insert was selected to be the founder (F0) for development 
of a ZIP9 -/- strain homozygous for knock-in of the stop codon cassette in exon 3. The F0 
was outcrossed with WT females to obtain F1 offspring. FI heterozygous carriers of the 
stop codon cassette were crossed to produce F2 offspring consisting of WT (ZIP9 +/+), 
homozygous mutants (ZIP9 -/-) and fish heterozygous at ZIP9 (ZIP9 +/-). The presence and 
absence of the stop codon cassette in exon 3 of F2 ZIP9 -/- and ZIP9 +/+ fish was confirmed 
by Sanger sequencing. The mutant line had a 64 nucleotide insert, consisting of the stop 
codon cassette (35 bp), and additional nucleotides introduced on both sides of the cassette 
(Figure 4.4A). 3 stop codons in each possible reading frame are present in the cassette, but 
a stop codon (TAA) encoded in nucleotides 3-5 of the insert is predicted to be in frame. 
The proposed protein sequence resulting from this mutation is presented in Figure 4.4B, 
with the WT protein containing 309 amino acids, and the mutant protein truncated at amino 
acid 95. 
Effect of ZIP9 mutation on fecundity 
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Measures of fecundity examined in ZIP9 +/+ and ZIP9 -/- fish included incidence of 
spawning, number of oocytes released, and fertilization rates. Female and male ZIP9 -/- fish 
showed no decrease in spawning incidence compared to sibling WT controls (Figure 4.5A). 
The number of oocytes spawned by females during mating events was significantly lower 
in ZIP9 -/- fish (106.7 ± 26.90) compared to ZIP9 +/+ siblings (277.3 ± 21.38) (Figure 4.5B). 
In addition, the percentage of fertilized eggs was significantly lower for eggs spawned by 
ZIP9 -/- (35.48% ± 9.611) than those by ZIP9 +/+ fish (96.77% ± 2.926) (Figure 4.5C). 
However, there was no significant difference in fertilization rate of eggs produced by WT 
females that were mated with ZIP9 -/- (97.50% ± 1.256) males or ZIP9 +/+ (91.79% ± 4.701) 
(Figure 4.5D). 
Effect of ZIP9 mutation on egg phenotype  
Inspection of eggs produced by ZIP9 -/- and ZIP9 +/+ females found many ZIP9 -/- 
eggs showed a different phenotype to that seen in eggs from WT fish (Figure 4.6A). 
Measurement of chorion diameters of eggs produced by ZIP9 +/+ and ZIP9 -/- females 
indicated that mutant females produce two distinct phenotypes, those with chorions of 
similar diameter to eggs produced by ZIP9 +/+ fish (regular egg diameter (RD); 1.203 ± 
0.007 mm, and 1.182 ± 0.007 mm, respectively), and those that are significantly smaller in 
diameter (small egg diameter (SD); 0.8100 ± 0.006 mm) (Figure 4.6B). All ZIP9 +/+ females 
used for analysis only spawned RD eggs (Figure 4.6C). However, ZIP9 -/- females showed 
a high level of variance between the number of RD and SD eggs produced between fish, 
with two fish producing only SD eggs, and two fish producing both phenotypes (Figure 
4.6D). When the percentage of RD eggs for all ZIP9 -/- and ZIP9 +/+ females are combined, 
the percentage of RD eggs produced by ZIP9 -/- females (34.80% ± 15.77) is significantly 
lower than that for ZIP9 +/+ siblings (100% ± 0.00) (Figure 4.6E). There was no significant 
difference in the relative percentages of RD (34.80 ± 15.77) and SD (65.20 ± 15.77) eggs 
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spawned by ZIP9 -/- females (Figure 4.6F). SD ZIP9 -/- eggs exhibited significantly lower 
fertilization rates (21.04% ± 6.783) compared to RD ZIP9 -/- eggs (67.40% ± 9.197) (Figure 
4.6G). 
Effect of ZIP9 mutation on larval edema and growth 
Edema incidence and growth measures were performed on F3 ZIP9 +/+ and ZIP9 -/- 
fish, with ZIP9 -/- larvae hatched RD and SD eggs examined independently. At 6 dpf, fish 
from SD ZIP9 -/- eggs showed a significantly higher incidence of edema (40.08% ± 9.582) 
compared to those hatched from ZIP9 +/+ (11.40% ± 4.030) or RD ZIP9 -/- eggs (15.36% ± 
5.833) (Figure 4.7A,B). Using the average number of eggs spawned (ZIP9 +/+, 277.3; ZIP9 
-/-, 106.7) fertilization rate (ZIP9 +/+, 96.8%; ZIP9 -/-, 35.5%), and incidence of edema (ZIP9 
+/+, 11.40%; ZIP9 -/-, 27.72% (avg of SD and RD)), a graph showing the number of 
surviving larva after day 6 from a representative spawn for each genotype was compiled in 
Figure 4.7C. While WT females produce an average spawn of 277 eggs with 91.3% (253) 
of larvae surviving at day 6, ZIP9 -/- females produce an average of 107 eggs per spawning 
event, and only 30.8% (33) of larvae would survive past day 6 on average. In the larval 
growth analyses, larvae from SD ZIP9 -/- eggs had a significantly larger yolk sac at 3 dpf 
compared to those from ZIP9 +/+ and RD ZIP9 -/- eggs (Figure 4.8A). No significant 
difference in yolk area was observed between the different genotypes/phenotypes at 0 dpf 
(data not shown), so the larger yolk sac present in 3 dpf larvae from SD ZIP9 -/- eggs may 
be due to inefficient yolk absorption. Analysis of larval growth under starvation conditions 
from 3-10 dpf, indicated that ZIP9 -/- fish from SD eggs were significantly shorter in length 
compared to ZIP9 +/+ fish at every time point (Figure 4.8B). SD egg ZIP9 -/- larvae were 
also significantly shorter than ZIP9 -/- fish from RD eggs at every time point except 9 dpf, 
which was the only time that ZIP9 -/- fish from RD eggs were significantly smaller than 
ZIP9 +/+ fish. In fish fed endogenously after 6 dpf, ZIP9 -/- fish from SD eggs were 
 90 
significantly smaller than larvae from RD ZIP9 -/- and ZIP9 +/+ eggs at 15 and 25 dpf, while 
ZIP9 -/- larvae from RD eggs showed no difference from ZIP9 +/+ fish at every time point 
(Figure 4.8C). Representative images of a ZIP9 +/+ and a ZIP9 -/- SD fish 15 dpf is presented 
in Figure 4.8D. 
Comparison of ovarian morphology of ZIP9 +/+ and ZIP9 -/- fish  
ZIP9 +/+ and ZIP9 -/- fish of similar length (ZIP9 +/+, 3.360 ± 0.06205 cm; ZIP9 -/-, 
3.190 ± 0.08124 cm), weight (ZIP9 +/+, 0.4460 ± 0.02182 g; ZIP9 -/-, 0.3560 ± 0.04874 g), 
and GSI (ZIP9 +/+, 16.02 ± 1.285%; ZIP9 -/-, 12.56 ± 2.518%) were selected for comparison 
of ovarian morphology. ZIP9 -/- fish ovaries had a significantly smaller proportion of 
perinuclear stage and a significantly higher proportion of cortical alveolus stage oocytes 
compared to ZIP9 +/+ fish (Figure 4.9A). However, no significant differences were 
observed in the proportions of oocytes at later stages of development between genotypes. 
Representative histological images of follicles from ovaries of each genotype are shown in 
Figures 4.9B. 
DISCUSSION 
Here we present evidence that testosterone mediates an apoptotic response in 
zebrafish G/T cells harvested from mature ovaries and that it is mediated by ZIP9. The 
apoptotic response in zebrafish involves rapid increases in intracellular zinc as well 
increased caspase 3 activity and mRNA expression of pro-apoptotic members, identical to 
that seen in the ZIP9-mediated apoptosis of croaker G/T cells (25,117). The finding that 
ZIP9 has the same function in two distantly-related teleost species belonging to the two 
largest superorders, Acanthopterygii (croaker) and Ostariophysi (zebrafish), suggests ZIP9 
mediation of ovarian G/T cell apoptosis is likely a shared response in teleosts. We further 
investigated the role of ZIP9 in ovarian physiology by developing a global ZIP9 knockout 
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model by utilizing a CRISPR-Cas9 system. ZIP9 -/- females showed significant reductions 
in fecundity, with decreased numbers of oocytes spawned and a reduction in oocyte quality 
as evident by reduced fertilization capacity and abnormal larval development. However, 
no abnormalities between ZIP9 -/- and ZIP9 +/+ ovarian morphology were apparent by 
histological examination. Overall, this study indicates while ZIP9 plays a role in apoptosis 
of ovarian follicle cells in vitro, the receptor likely also has other functions in the teleosts 
ovary, potentially in the maturation and/or activation responses of oocytes.  
This study demonstrates that the ZIP9-mediated apoptotic response exhibited by 
G/T cells in vitro is shared by Atlantic croaker, zebrafish, and potentially all teleosts. ZIP9 
is 85% homologous between zebrafish and croaker, and while croaker ZIP9 is predicted to 
have 7 transmembrane (TM) domains, zebrafish and human ZIP9 are predicted to have 8 
TM domains (25). It is unknown if this difference in ZIP9 structure results in differences 
in androgen-induced signaling mediated by the receptor. ZIP9 mediates androgen-induced 
apoptosis by coupling to a Gs in croaker G/T cells but mediates a very similar response in 
human cancer cell lines through activation of a Gi. Further examination of Gα-subunit 
signaling events and ZIP9-G protein coupling will be essential in determining if the 
apoptotic response observed in zebrafish G/T cells is mediated through ZIP9 coupling to a 
Gi or Gs. An additional complexity of ZIP9 signaling has been observed in the croaker G/T 
cells model, in which ZIP9 alternatively couples to Gs and Gi to mediate opposite 
physiological responses depending on the developmental stage from which the G/T cells 
are derived. ZIP9-Gs coupling dominates in late stage croaker ovarian follicles and 
mediates the androgen-induced apoptotic response. When croaker G/T cells from all stage 
follicles are pooled, androgen-induced apoptosis is the primary response observed. 
Zebrafish are daily spawners that maintain an asynchronous store of follicles in the ovary, 
similar to that seen in croaker during their reproductive season (128). Therefore, there is a 
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potential that if dual signaling events are mediated by ZIP9 activation in zebrafish G/T 
cells, one pathway may dominate due to the mixed population of follicles from which the 
G/T pool is derived. Further investigation of dual coupling of ZIP9 to multiple G proteins 
in the zebrafish G/T cell model would help test this possibility. 
This study is the first to utilize a ZIP9 global knockout to investigate the role of the 
receptor in reproduction. ZIP9 -/- males show no abnormal reproductive phenotype based 
on spawning incidence and fertilization rate. However, ZIP9 -/- females show significant 
reductions in fecundity compared to WT siblings, with fewer eggs spawned, lower 
fertilization rates, and high incidences of edema in surviving larvae. Of interest, the 
reduction in fecundity of mutant females does not appear to be due to oogenesis, as 
apparent from the similar proportions of vitellogenic follicles produced in WT and mutant 
female ovaries. Therefore, the differences in egg phenotype, fertilization rates, and health 
of mutant larvae, likely arise during the process of oocyte maturation or activation. Oocyte 
maturation occurs when the germinal vesicle breaks down and meiosis proceeds to 
metaphase II where it remains arrested until fertilization (148). In zebrafish, egg activation 
occurs upon exposure to the external spawning media and involves a wave of free 
intracellular Ca++ (149,150) inducing cortical granule exocytosis, which results in the 
separation of the chorion from the vitelline (plasma) membrane to create a perivitelline 
space (149,151). The increase in free Ca++ also allows programmed development to 
proceed. Interestingly in zebrafish, since activation is not dependent on fertilization, the 
developmental program will ensue within ~30s of activation with or without fertilization. 
However unfertilized eggs will only divide several times before cleavage failure (149). If 
sperm is present and the egg undergoes fertilization, meiosis is completed, and the egg 
develops normally (149,150). Of interest, androgens and zinc have been found play a role 
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in oocyte maturation and activation, respectively, in a variety of models 
(44,45,137,138,152–155).  
Androgens have been shown to stimulate oocyte maturation in Xenopus (44,45), 
murine (156) and porcine models (153). In Xenopus, progestins are also potent promoters 
of oocyte maturation (44,157,158) and are widely accepted as the primary maturation-
inducing steroid (MIS) in amphibians, as they are in teleosts (97,159). The regulation of 
maturation of mammalian oocytes is less clear, as steroids have not been shown to be 
obligatory to the induction of LH-mediated oocyte maturation (160). Additionally, high 
doses of androgens are required to induce maturation of murine and porcine oocytes, which 
suggests these responses may not be physiologically relevant (161). As previously 
mentioned, the role of progestins in the mediation of teleost oocyte maturation has been 
extensively established and is well accepted (97,159,162). This along with little support 
that androgens are fundamental in oocyte maturation in other models suggests that the 
abnormal phenotype of eggs produced by ZIP9 -/- females may be due to disruption in an 
alternative process, such as egg activation.  
In zebrafish, oocyte activation is essential to complete meiosis and begin embryonic 
development. The most identifying feature of egg activation is the rapid rise in free 
intracellular Ca++ which has been observed in all vertebrate (Xenopus (163); teleosts 
(149,164); mammals (165,166)) and invertebrate (Drosophila (167); C. elagans (168)) 
models examined to date. In addition to Ca++, a role for zinc in egg activation has recently 
been proposed in mammals (137,138,154,155). The mammalian oocyte undergoes 
dramatic zinc accumulation between GVBD and metaphase II (MII), with progression to 
MII being halted if zinc is chelated (137). This zinc accumulation ensures meiotic arrest at 
MII until the egg is activated at fertilization. In mice, non-human primates and humans, a 
rapid zinc “spark”, or release from the egg, immediately follows the fertilization-induced 
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free Ca++ wave (138,154). Furthermore, mammalian eggs arrested in MII undergo 
parthenogenetic cell cycle resumption when zinc is chelated (138,155), indicating that the 
Ca++ wave may not be essential for meiosis resumption, but a reduction of intracellular zinc 
is. An elevation of intracellular zinc using pharmacological agents after the resumption of 
meiosis II will once again arrest the egg at metaphase, inhibiting cell cycle progression and 
embryo development (138). Overall, these studies indicate that in the mammalian eggs, 
zinc regulation is important to both maturation and activation processes, with increases in 
egg zinc content being associated with maturation (resumption of meiosis to MII), and a 
decreased intracellular zinc resulting in meiosis II resumption, completion of meiosis, and 
subsequent embryo development. Free zinc signaling has not been well examined in teleost 
oocytes to date, however zinc levels in the oocyte increase over the course of development 
(140) similar to as seen in mammalian oocytes (137). Thus, it remains unclear if the role 
of zinc in oocyte maturation/activation is unique to mammals, or shared in vertebrates or 
all animal phyla as the Ca++ activation wave is.  
The phenotype of the ZIP9 -/- eggs with small chorion diameter is remarkably 
similar to that observed by Mei et al. 2009 (169) in zebrafish with a mutated heterogeneous 
nuclear ribonucleoprotein I (hnRNP I). hnRNP I mutants showed normal oogenesis but 
were defective in the IP3-mediated rise in Ca
++ associated with egg activation, which 
resulted in cortical granule exocytosis failure. This produced a phenotype of decreased 
chorion elevation, resulting in an egg with a smaller chorion diameter. These eggs showed 
varying amounts of cytoplasmic segregation to the animal pole and cleavage defects, 
ultimately resulting in high mortality (169). Interestingly, there was high variability 
between individual clutches produced by mutant females, with variable proportions of 
activated and non-activated eggs (between 27-94% egg showed defective activation) (169). 
The non-activation phenotype was rescuable with injection of Ca++ or IP3 into the embryo, 
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suggesting that hnRNP I acts upstream of IP3 activation. The similarities in the phenotype 
of the smaller diameter chorion eggs, and the variability in the extremity of abnormality 
between individual eggs, clutches, and spawning females observed in ZIP9 -/- and hnRNP 
I mutants suggest that both proteins are likely involved in the signaling pathway that 
mediates egg activation in zebrafish. However, further verification of this is required to 
determine the role of ZIP9 and where it lies on this pathway. It is also important to note, 
that neither ZIP9 or hnRNP I mutation results in full failure of oocyte activation, suggesting 
that there may be additional means of compensation for oocyte activation in the zebrafish 
model. Further examination of the roles of ZIP9 and zinc signaling in zebrafish oocyte 
maturation and activation in vitro using WT and ZIP9 mutant fish will potentially clarify 
the SD chorion phenotype observed in ZIP9 -/- fish. 
While this examination of ZIP9 -/- zebrafish has provided evidence for a role of 
ZIP9 in female reproduction, a role for ZIP9 in androgen-induced apoptosis in vivo was 
not apparent. Apoptosis is generally confined to atretic and postovulatory follicles in the 
fish ovary (82–84), with atresia typically occurring under stress and postovulatory follicle 
breakdown occurring after a spawning event. In the current study, atretic and postovulatory 
follicles were absent in the histological preparations of ZIP9 +/+ and ZIP9 -/- fish ovaries, 
which was expected since the fish had not recently spawned (>3 days) or undergone 
environmental stress. It would be of interest to examine the ovaries of ZIP9 +/+ and ZIP9 -/- 
fish after spawning or induction of stress to identify potential differences in apoptotic 
responses between the strains. 
It should be emphasized that induction of both apoptosis and zinc transport can be 
mediated by numerous proteins, and therefore, compensation of ZIP9-mediated events in 
a global knockout model would not be surprising. Compensation of physiological functions 
of proteins involved in reproduction is well documented in teleost knockout models. For 
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example knockout of GnRH, kisspeptin 1 and 2 (reviewed in (170)), and the LH receptor 
(171) show no abnormal reproductive phenotypes in zebrafish. Apoptosis is essential for 
the maintenance of homeostasis in all tissues, with numerous endocrine, autocrine and 
paracrine factors being able to influence apoptosis and survival of cells in a tissue at any 
given time (172,173). Furthermore, there are 19 members of the ZnT (Slc30A) and ZIP 
(Slc39A) families of zinc transporters in zebrafish (141), many of which are highly 
expressed in the zebrafish ovary. Therefore, while it is of interest to continue the 
examination of ZIP9 knockout model phenotypes to infer physiological roles of the 
receptor, there is the potential that some ZIP9-mediated functions will not result in 
abnormal phenotypes due to compensation by other physiological processes. Additional 
investigation of the ZIP9 global knockout phenotypes, as well as its use in in vitro 
experimentation, will be essential in understanding ZIP9’s role in the zebrafish ovary. 
In summary, the present study demonstrates that ZIP9 mediates androgen-induced 
apoptosis in croaker and zebrafish G/T cells, and that this response is likely conserved in 
teleosts. Investigation of the role of ZIP9 in the zebrafish ovary using a global knockout 
model demonstrated that ZIP9 -/- females showed a severe reduction in fecundity compared 
to WT fish. This reduced fecundity is primarily driven by a non-activated oocyte 
phenotype, with a large proportion of spawned eggs showing lack of chorion elevation, 
low fertilization rates, and high incidences of edema in fish that do develop from the eggs. 
This suggests a role of ZIP9 in zebrafish oocyte maturation and/or activation, however 
further work looking into the mechanism driving this phenotype is required. Additionally, 
examination of apoptotic events in the ovary in vivo as well as using the global knockout 
model to examine loss of ZIP9’s apoptotic function in ZIP9 -/- G/T cells in vitro will provide 
further insight into the role of ZIP9 in ovarian apoptosis. Overall, the work presented in 
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this study strongly suggests an important role for ZIP9 in teleost ovarian physiology and 
highlights the need for future research on this receptor in animal reproductive physiology. 
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FIGURES 
 
 
 
Figure 4.1: Tissue distribution of ZIP9 mRNA expression and androgen binding to ovarian 
plasma membranes. A, Relative ZIP9 mRNA levels in various zebrafish tissues. B, relative 
ZIP9 mRNA levels in non-reproductive tissues. C, Displacement of membrane-bound 
[3H]T by unlabeled testosterone and various steroid hormones. All data represents means 
± SEM, n=3-6 (A,B), n=9 (C). Significance was determined by one-way ANOVA with 
Bonferroni multiple comparison post-test. Different letters indicate significant differences 
between the treatment groups in the post hoc test at p < 0.05. ZIP9 mRNA expression was 
determined in tissue samples from 3 females and 3 males, with sexes combined for analysis 
of non-reproductive tissues. For binding experiments, each treatment was conducted in 
triplicate with similar results obtained for each, and the experiment was repeated 3 times. 
Ctl, total binding; P4, progesterone; E2, estradiol; Mib, mibolerone. 
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Figure 4.2: Effect of testosterone on apoptosis, caspase 3 activity, pro-apoptotic member 
mRNA expression and intracellular free zinc. A, Effects of various androgen treatments on 
% apoptotic nuclei as determined by Hoechst staining. B, Effect of testosterone on caspase 
3 activity. C, Expression of p53 and bax mRNA after 24 hr testosterone treatment of G/T 
cells. D, Effect of testosterone on intracellular free zinc levels. All data represents means 
± SEM, n=8-9 (A-C), n=3 (D). Significance was determined by Student’s t-test (B-D; *, 
p<0.05, **, p<0.01, ***, p<0.001) or one-way ANOVA with Bonferroni multiple 
comparison post-test (A). Different letters indicate significant differences between the 
treatment groups in the post hoc test at p < 0.05. Incidence of apoptosis (A) and caspase 3 
activity (B) experiments were repeated with 3 pools of G/T cells and each treatment 
conducted in duplicate or triplicate with similar results obtained for each. Pro-apoptotic 
member mRNA expression analysis (C) was repeated with 4 pools of G/T cells and each 
treatment conducted in duplicate. Intracellular zinc was assessed in 3 pools of G/T cells. 
Veh, ethanol vehicle; T, testosterone; Mib, mibolerone; TBSA, bovine serum albumin-
conjugated testosterone. 
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Figure 4.3: Role of ZIP9 in 
testosterone-induced apoptosis as 
determined by TUNEL staining. A-
B, Effect of transfection of siRNA 
targeting-ZIP9 and ZIP9 ORF 
expression plasmid on testosterone-
induced apoptosis (A) and ZIP9 
protein expression (B). All data 
represents means ± SEM, n=6 (A), 
n=3 (B). Significance was 
determined by one- (B) or two-way 
(A) ANOVA followed by Bonferroni 
multiple comparison post-test. 
Different letters indicate significant 
differences between the treatment 
groups in the one-way ANOVA post 
hoc test at p < 0.05. Level of 
significance between vehicle and 
testosterone treatments as determined 
by the two-way ANOVA post hoc are 
indicated as ***, p<0.001. In 
experiment (A) significant 
interactive effects of the steroid 
treatment (V & T) and the 
transfection treatments on G/T cell 
apoptosis was detected by the two-
way ANOVA, which was predicted 
because ZIP9-targeting siRNA 
blocked the testosterone-induced 
responses, while effects of 
transfection with control siRNA and 
the expression plasmid did not. Experiments were repeated with three fish and each 
treatment conducted in duplicate with similar results obtained for each. NT, no 
transfection; Ctl, non-targeting siRNA control; Si, small interfering RNA, ZIP9, ZIP9 ORF 
expression plasmid. 
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Figure 4.4: Disruption of ZIP9 exon 3 by a CRISPR-Cas9 system. A, Schematic 
representation of genomic ZIP9, and the comparison of mutant (ZIP9 -/-) and wild-type 
(ZIP9 +/+) exon 3 nucleotide sequence. B, Comparison of predicted mutant and wild-type 
ZIP9 protein sequence. Highlighted nucleotide sequence indicated the stop codon cassette, 
red-text nucleotides indicate stop codons, red boxed-amino acids are adjacent to the site of 
early truncation in the mutant ZIP9. 
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Figure 4.5: Measures of fecundity in ZIP9 mutant and wild-type zebrafish. A, Breeding 
occurrence in male and female ZIP9 -/- and ZIP9 +/+ fish mated with breeding-confirmed 
wild-type fish of opposite sex. B, Number of eggs ovulated by ZIP9 -/- and ZIP9 +/+ in single 
breeding events. C, Percent of eggs ovulated by ZIP9 -/- and ZIP9 +/+ females that underwent 
successful fertilization when mated with wild-type males. D, Percent of eggs ovulated by 
wild-type females that underwent successful fertilization when mated with ZIP9 -/- and 
ZIP9 +/+ males. All data represents means ± SEM, n=4-5 (A), n=9-10 (B-D). Significance 
was determined by Student’s t-test (***, p ≤ 0.0001). Experiments were repeated with 5 
male and 5 female ZIP9 +/+ fish, and 5 male and 4 female ZIP9 -/- fish, that were each 
spawned on 2 separate occasions. 
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Figure 4.6: Analysis of egg phenotypes produced by ZIP9 -/- and ZIP9 +/+ fish.  
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Figure 4.6 (continued): Analysis of egg phenotypes produced by ZIP9 -/- and ZIP9 +/+ fish. 
A, A representative image of small diameter egg phenotype and regular egg phenotype. B, 
Chorion diameter of eggs spawned by ZIP9 -/- and ZIP9 +/+ females. C, Relative proportion 
of regular and small diameter eggs spawned by individual ZIP9 +/+ females. D, Relative 
proportion of regular and small diameter eggs spawned by individual ZIP9 -/- females. E, 
Percentage of regular diameter eggs spawned by ZIP9 -/- and ZIP9 +/+ females. F, Proportion 
of regular diameter and small diameter eggs spawned by ZIP9 -/- females. G, Percent of 
small diameter and large diameter eggs spawned by ZIP9 -/- females that underwent 
successful fertilization. All data represents means ± SEM, n=50 (B), n=2 (C, D), n=9-10 
(E, F), n=4-8 (G). Significance was determined by Student’s t-test (**, p<0.01, ***, 
p<0.001) or by one-way ANOVA with Bonferroni multiple comparison post-test. Different 
letters indicate significant differences between the treatment groups in the post hoc test at 
p < 0.05. Chorion diameter analyses were performed by measuring 25 eggs from 2 
spawning events. Percentages of regular and small diameter eggs (C, D) was determined 
from 2 spawning events for each individual spawning events. Experiments (E-G) were 
repeated with 5 female ZIP9 +/+ fish, and 4 female ZIP9 -/- fish, that were each spawned on 
2 separate occasions. SD, small diameter egg; RD, regular diameter egg. 
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Figure 4.7: Analysis of ZIP9 -/- and ZIP9 +/+ larvae health. A, Incidence of pericardial and 
yolk sac edema in 6 dpf ZIP9 -/- and ZIP9 +/+ larvae. B, Representative image of 6 dpf larvae 
showing regular development (ZIP9 +/+) and pericardial/yolk sac edema (ZIP9 -/- SD). C, 
Ideal representation of surviving fish of each genotype from an average spawning event. 
All data represents means ± SEM, n=4-5. Significance was determined by one-way 
ANOVA with Bonferroni multiple comparison post-test. Different letters indicate 
significant differences between the treatment groups in the post hoc test at p < 0.05 (A). 
Edema incidence was determined on larvae spawned from 4-5 separate events for each 
genotype/phenotype. Averages previously reported for # eggs spawned, fertilized, and 
larval incidence of edema were used to construct a graph showing surviving fish at 6 dpf 
for each genotype. SD, small diameter egg; RD, regular diameter egg. 
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Figure 4.8: Analysis of ZIP9 -/- and ZIP9 +/+ larvae growth. A, Yolk sac area of 3 dpf ZIP9 
-/- and ZIP9 +/+ larvae. B, Length of ZIP9 -/- and ZIP9 +/+ larvae under starvation conditions 
between 3-10 dpf. C, Length of ZIP9 -/- and ZIP9 +/+ larvae fed endogenously after 6 dpf. 
D, Representative image of 15 dpf ZIP9 +/+ and ZIP9 -/- SD larvae. All data represents means 
± SEM, n=20 (A), n=15-22 (B) For (C), n=20 (6-10 dpf); n= 40-55(15, 25 dpf ZIP9 +/+ & 
ZIP9 -/- RD); n=37 (15 dpf ZIP9 -/- SD); n=8 (25 dpf ZIP9 -/- SD). Significance was 
determined by one-way ANOVA with Bonferroni multiple comparison post-test. Different 
letters indicate significant differences between the treatment groups in the post hoc test at 
p < 0.05 (A). For growth analysis, * indicates significance difference from WT, while # 
indicated significant difference from ZIP9 -/- RD. Growth analyses were performed on 
approximately 10 fish from 2 separate spawning events for time point and each 
genotype/phenotype (specific n values listed above). SD, small diameter egg; RD, regular 
diameter egg. 
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Figure 4.9: Ovarian morphology of ZIP9 -/- and ZIP9 +/+ fish. A, The relative proportion 
of ovarian follicles at different stages of development in ZIP9 -/- and ZIP9 +/+ ovaries. B, 
Representative images of histological ovarian preparation from ZIP9 -/- and ZIP9 +/+ fish. 
All data represents means ± SEM, n=5. Significance was determined by Student’s t-test (*, 
p<0.05). The analysis was performed with 5 ZIP9 -/- and ZIP9 +/+ females. PNS, perinuclear 
stage; CA, cortical alveoli stage; EV, early vitellogenic stage; MV, mid vitellogenic stage; 
LV, late vitellogenic stage. 
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SUPPLEMENTAL DATA 
 
 
Table 4.1: Sequence of primers (5’-3’) used for qPCR experiments (Chapter 4). 
 
 
 
 
Table 4.2: Oligonucleotide sequences used in gRNA generation and stop codon cassette. 
Exon 3 specific- blue, T7 promoter; red, target sequence of gRNA; orange, complementary 
region. tracrRNA tail- orange, complementary region. Exon 3 specific stop codon cassette- 
red, stop codon cassette. 
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Table 4.3: Primers used in mutation screening assays. 
 
 
 
Figure 4.10: Representative images of screening used for detection of mutations and stop 
codon insertion. A, Representative HMA screening, additional bands (+) from what is 
observed in WT (non-injected fish) indicate a CRISPR-Cas9-induced mutation in exon 3. 
B, Stop cassette screening, bands indicate the fish is positive (+) for insert of the stop codon 
cassette. C, Screening for homo/heterozygous ZIP9 fish. The 64 bp insertion can be 
detected by running on an agarose gel. Fish denoted by ZIP9 genotype, +/-, possesses both 
WT and stop codon insert; -/-, homozygous for stop codon insert; +/+, homozygous WT. 
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Chapter 5:  Summary and Conclusions 
The results of the present study demonstrate that ZIP9 mediates androgen-induced 
apoptosis of both Atlantic croaker and zebrafish G/T cells in vitro. Both of these apoptotic 
responses involve a rapid rise in intracellular free zinc, upregulation of pro-apoptotic 
member mRNA, and increased caspase 3 activity. Thus, these downstream physiological 
responses mediated by ZIP9 may be conserved in all teleosts. However, while the apoptotic 
response in croaker G/T cells was found to involve activation of a stimulatory G protein 
and MAPK activity, rapid signaling events initiated by ZIP9 in zebrafish G/T cells are 
unknown. Further investigation of G protein coupling and kinase signaling members would 
provide insight into how similar ZIP9-mediated apoptotic signaling is between croaker and 
zebrafish G/T cell models.  
This work also demonstrates that androgens act to promote both apoptosis and 
survival in croaker G/T cells through activation of ZIP9. These differential responses to 
androgens can be attributed to the follicle stage from which the G/T cells are harvested, 
with testosterone treatment decreasing apoptosis in early stage follicle G/T cells, and 
inducing apoptosis of late stage follicle G/T cells. ZIP9 mediates these differential 
physiological responses by coupling to and activating different G proteins depending on 
the G/T cell stage. The apoptotic response exhibited by late stage follicle G/T cells involves 
ZIP9-Gs coupling, which was previously observed by Berg et al., 2014 in G/T cells from 
fish at the peak of reproduction. ZIP9 couples to a Gi in early stage G/T cells and involves 
opposite trends in many of the responses characterized in the apoptotic response. Thus, Gi 
signaling is likely inhibitory to apoptosis, while Gs signaling promotes apoptosis in the 
croaker G/T cell model. The zinc transporter function of ZIP9 also appears to play a role 
in both pro- and anti-apoptotic responses, with a rise in intracellular free zinc being 
required for induction of apoptosis (25), while the anti-apoptotic response coincides with 
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a testosterone-induced reduction in intracellular free zinc. This ZIP9-G protein coupling 
switch that occurs in croaker G/T cells would allow ovarian follicles to respond to the same 
stimuli in a follicle stage-dependent manner, and thus, undergo physiological processes 
independently of one another. In the ovary, testosterone may help protect follicles during 
primary and early secondary growth, but act as an apoptotic factor in follicles at the final 
stages of development, potentially to aid in follicle rupture or breakdown of cells remaining 
after ovulation. However, the role of ZIP9 in these processes has not been verified to date. 
Additionally, it should be noted that the mechanism that drives the switching in ZIP9-G 
protein coupling remains unknown. Further investigation of this switch in the croaker G/T 
model may give valuable insight into potential properties of ZIP9 in other models such as 
human cancer cells in which ZIP9 is highly expressed and promotes apoptosis (26). It also 
remains unknown if differential ZIP9-G protein coupling occurs in zebrafish G/T cells. 
This study is the first to examine a global ZIP9 knockout model. Development of a 
ZIP9 knockout strain of zebrafish allowed for a broad examination of reproductive 
phenotypes that are associated with the mutant genotype. While ZIP9 knockout males 
showed no reduction in the ability to fertilize eggs, female knockouts had a significant 
reduction in fecundity compared to wild-type fish. Eggs spawned by ZIP9 knockouts 
consisted of a high proportion that displayed an abnormal phenotype characteristic of 
failure to activate. Eggs with this abnormal phenotype showed severe reductions in 
fertilization and produced larvae that showed a significantly higher incidence of edema and 
reduced growth compared to wild-type larvae and those hatched from normal phenotype 
ZIP9 knockout eggs. Of interest, while egg activation involves a wave of free Ca++ in all 
animals, zinc has recently been shown to also play an essential role in mammalian egg 
activation (137,138,155). Therefore, it is of interest to further investigate the role of zinc 
in teleost egg activation and examine the role of ZIP9 in zinc regulation of oocytes.  
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Finally, while the current study examined broad reproductive measures using ZIP9 
knockout and wild-type models, there are additional studies that should be performed using 
the mutant model to further investigate ZIP9’s role in the ovary. The current study has 
highlighted multiple roles of ZIP9 in teleost G/T cells in vitro, but the apoptotic (and 
potentially anti-apoptotic) actions of ZIP9 were not verified in the global knockout 
zebrafish model. Use of the mutant fish in in vitro experimentation will be essential in 
verifying the apoptotic effect observed in wild-type G/T cells. Furthermore, apoptotic 
events can be examined in vivo by inducing atresia through environmental stressors or 
examination of postovulatory breakdown after controlled spawning events. In vitro 
examination of egg maturation and activation in both mutant and wild-type eggs will also 
verify if ZIP9 is involved in these processes. In addition, generation of a conditional or 
inducible ZIP9 knockout model would aid in the examination of the role of the receptor in 
ovarian physiology without the potential influence of ZIP9 knockout effects on other 
tissues in the hypothalamus-pituitary-gonad axis. Thus, the use of both wild-type and ZIP9 
knockout models will be essential in understanding the physiological roles of the receptor 
in the teleost ovary. In conclusion, this dissertation confirms the hypothesis that ZIP9 plays 
an important role in the teleost ovary, however, additional studies are required to make 
mechanistic links between the in vitro and in vivo data acquired.  
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